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RESUMO 
 
FIBROPAPILOMATOSE E O CHELONIA HERPESVÍRUS 5 EM TARTARUGAS-VERDES 
DE ÁFRICA OCIDENTAL. 
 
A avaliação da sanidade de animais selvagens é uma preocupação crescente, à medida que 
mais evidências apontam para a ligação intrínseca entre o meio ambiente e a saúde animal. 
A fibropapilomatose (FP) é uma doença neoplásica panzoótica que afeta tartarugas 
marinhas, principalmente tartarugas-verdes. Embora os tumores sejam benignos, quando 
atingem dimensões maiores podem impedir funções vitais e levar à morte das tartarugas. A 
FP está relacionada com a presença de uma infeção pelo Chelonid herpesvirus 5 (ChHV5) e 
em paralelo com a degradação dos habitats de alimentação das tartarugas.  
A Guiné-Bissau e a Mauritânia são hotspots para as tartarugas-verdes, sustentando a maior 
população desta espécie em África, no entanto, até à data, não existia informação científica 
sobre a prevalência de FP nestas áreas.  
Este estudo analisou 108 tartarugas-verdes capturadas entre 2018 e 2019 quanto à 
presença de FP e utilizou a PCR em tempo real (qPCR), após implementação e validação 
deste método, para detetar a presença do Chelonid Herpesvirus 5 (ChHV5) em 76 desses 
indivíduos. Fragmentos da glicoproteína B, UL18, UL34 e ADN polimerase também foram 
amplificados a partir das amostras da Guiné-Bissau e da Mauritânia, por PCR convencional, 
e sequenciados, para inferência filogenética.  
Os resultados mostraram uma prevalência de FP de 27% (n=32): 36% em Guiné-Bissau e 
28% na Mauritânia. A probabilidade de contrair FP decresce com o aumento do tamanho 
das tartarugas e a maioria dos animais com FP estavam apenas ligeiramente afetados pela 
doença. Analisaram-se 28 biópsias de tumores, das quais 24 (86%) foram positivas para o 
ADN de ChHV5, tal como 32 (42%) das 76 amostras de pele saudável examinadas. A 
análise filogenética revelou que as sequências virais se separaram em quatro grupos 
filogeográficos: Pacífico Este, Atlântico Ocidental / Este das Caraíbas, Centro-Oeste do 
Pacífico, e Atlântico. As sequências da Guiné-Bissau e da Mauritânia agruparam com 
exemplares do Atlântico.  
A prevalência de FP foi moderada comparativamente com áreas de maior atividade 
antropogénica, o que era esperado, dado que os locais de estudo têm baixo impacto 
humano. As tartarugas mais jovens parecem mais suscetíveis à FP, possivelmente por 
serem naïves à doença e a adquirem no local de alimentação costeira. A deteção de ChHV5 
na maioria das amostras de tumores é consistente com o seu papel como agente etiológico 
de FP. No entanto, em algumas das tartarugas assintomáticas também se detectou ADN do 
ChHV5, sugerindo a implicação de outros fatores na expressão da doença. A análise 
filogeográfica sugere um fluxo genético de ChHV5 ao longo da costa oeste de África, 
possivelmente mediado pela migração de tartarugas infetadas.  
Este estudo estabeleceu linhas de base sobre a prevalência de FP e de infeção por ChHV5 
para tartarugas-verdes da África Ocidental. Estes dados podem ser usadas para avaliar os 
impactos da atividade antropogénica e alterações climáticas. É aconselhado a monitorização 
sistemática desta doença para avaliar a sua evolução nestes locais-chave. 
 
 
Palavras-chave: Fibropapilomatose, tartaruga-verde, Chelonia mydas, Chelonid 
Herpesvírus 5, ChHV5, Guiné-Bissau, Mauritânia, Análise filogenética  
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ABSTRACT 
 
FIBROPAPILLOMATOSIS AND THE ASSOCIATED CHELONID HERPESVIRUS 5 IN 
GREEN TURTLES FROM WEST AFRICA 
 
The health assessment of free-ranging animals is an increasing concern as more evidence 
points to the intrinsic link between the environment and animal health. Fibropapillomatosis 
(FP) is a tumorigenic widespread disease affecting sea turtles, with more incidence among 
green turtles, Chelonia mydas. Although benign, large FP tumours can impede vital 
functions, such as feeding, vision and swimming, and impede organ function, leading to 
death. FP is a multifactorial disease, putatively linked to an infection by the Chelonid 
herpesvirus 5 (ChHV5) and to degraded habitats.  
Guinea-Bissau and Mauritania are hotspots for the green turtle in the Eastern Atlantic. 
Guinea-Bissau hosts the largest rookery for this species in Africa, with strong connectivity 
with foraging grounds in Mauritania. However, until this date no information was available 
concerning the prevalence of FP and of ChHV5 in these sites.   
This study analysed 108 green turtles, captured between 2018 and 2019, for the presence of 
FP, and used real-time PCR (qPCR) for the detection of ChHV5 DNA in 76 of those 
individuals. Partial sequences of the ChHV5 UL34 gene were amplified by conventional PCR 
and sequenced for phylogenetic analysis, including published sequences of ChHV5. The 
results showed an FP prevalence of 27% (n=32): 36% in Guinea-Bissau and 28% in 
Mauritania. FP probability decreased with increasing body size and most turtles were only 
mildly affected. From 28 tumour biopsies analysed, 24 (86%) were positive for ChHV5 DNA, 
as were 32 (42%) of 76 samples of the normal skin from both FP-afflicted and asymptomatic 
turtles. The phylogenetic analysis segregated viral variants into four groups: Eastern Pacific, 
Western Atlantic/Eastern Caribbean, Mid-west Pacific and Atlantic, and sequences from 
Guinea-Bissau and Mauritania clustered with the Atlantic group. FP prevalence cannot be 
compared to nearby geographical sites due to lack of information however, when compared 
with human-disturbed areas it was moderate, which was expected as our study sites have 
low human impact. Smaller turtles were more susceptible to FP, potentially because larger 
individuals acquire resistance over time. Detection of ChHV5 in most tumour samples is 
consistent with its role as aetiological agent of FP, however some asymptomatic turtles were 
also infected, supporting that other factors are involved in disease expression. We found 
evidence for recent ChHV5 gene flow along the West coast of Africa, potentially mediated by 
the migration of infected turtles. This study has established baselines on FP and ChHV5 
prevalence for West Africa green turtles, which can be used to assess impacts of 
anthropogenic activities or climate change in the near future. Systematic monitoring is 
advisable to assess evolution of disease at these key sites. 
 
 
Keywords: Fibropapillomatosis, Green turtles, Chelonia mydas, Chelonid Herpesvirus 5, 
ChHV5, Guinea-Bissau, Mauritania, Phylogenetic analysis 
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TRAINING PERIOD ACTIVITIES 
The curricular internship is inserted within the Study Plans for a Master’s degree in 
Veterinary Medicine at the Faculty of Veterinary Medicine (Faculdade de Medicina 
Veterinária- FMV). The official period in which the internship occurred was from October 
2018 until June 2019, and consisted of two parts: field and laboratorial work. 
 
Field work 
This part of the internship was conducted in the Bijagós Islands, situated northeast of the 
country Guinea-Bissau in West Africa, where two fieldtrips were conducted. A total of 4 
weeks were spent there, from the 20th of October until the 10th of November and then from 
the 23rd to the 29th of March 2019. The first part of the field work was based on the island of 
Unhocomozinho and Unhocomo Grande. Here, the work consisted in capturing juvenile sea 
turtles from in the water for processing and sample collection. The second part of the field 
work was conducted at Poilão Island, a nesting site for the green sea turtle (Chelonia 
mydas). The work was carried out under the guidance of Doctor Ana Rita Caldas Patrício, 
Post-Doctoral researcher at MARE – Marine and Environmental Sciences Centre, ISPA, 
Portugal & University of Exeter, UK.  
 
Laboratorial work 
The investigation was done at the Instituto Nacional de Investigação Agrária e Veterinária 
(INIAV) under the supervision and guidance of Doctor Margarida Duarte, of the Virology 
Laboratory of INIAV and Professor Ana Isabel Simões Pereira Duarte, of the Virology and 
Molecular Biology Laboratory (CIISA), Faculty of Veterinary Medicine (FMV) of the University 
of Lisbon (ULisboa).  
To develop my study I used several techniques such as:  
 DNA extraction and quantification 
 PCR 
o Real-time PCR 
o Conventional PCR  
o Nested PCR 
 Producing and transforming competent cells 
 DNA purification from agarose gels 
 Enzyme hydrolyse 
 DNA sequencing 
Additionally, I also learned computer methodologies for obtaining, analysing and 
manipulating genetic data. For this I used Clustal Omega, Mega X, DNA Baser, BEAST and 
R. For the statistical analyses I used RStudio.  
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Figure 1- A work-flow diagram of the structure of Section 1- State of the Art. 
Conservation 
Medicine 
Sea turtles 
Fibropapillomatosis 
Objectives 
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1. STATE OF THE ART (Figure 1) 
1.1. Conservation Medicine 
1.1.1. Definition of Conservation Medicine 
Conservation medicine, a concept that first appeared in the literature in the 1990s, describes 
the vast ecological framework of health. It represents an arising interdisciplinary field that 
studies the two-way interactions between certain pathogens and diseases as well as 
between species and ecosystems (Aguirre, Ostfeld, Tabor, House, & Pearl, 2002). It 
examines the world and ecological health problems through the conjugation of the studies of 
the environment, animals and humans. All three are intimately related and, in order to better 
understand and remedy ecological health problems, multiple disciplines are needed (Deem, 
2015b).  
The ultimate goal of Conservation Medicine is to create healthier ecosystems, to conserve 
biodiversity, and to recognise and treat diseases that affect rare or endangered species. It 
also studies both the impacts of changes in the global biodiversity and how that affects the 
preservation and transmission of diseases (Aguirre et al., 2002). Biodiversity is a broad term 
for biological variety, that englobes the wide variety of genes, species and ecosystems that 
constitute life on Earth. It provides a number of essential services, social and economic 
contributions from natural ecosystems (Rands et al., 2010).  
Within the past two decades, the human population has grown exponentially, surpassing 
seven billion individuals in the year 2012. This has led to an increased anthropogenic 
pressure on the environment and has put the long-term survival of several wildlife species at 
risk. Climate change, habitat degradation, introduction of invasive species, illegal trade of 
wildlife and exposure to emerging pathogens are major threats to biodiversity. More 
importantly these threats can have synergistic effects, i.e. one can potentiate the other. For 
example, global warming can lead to altered host-pathogen interactions and increase 
disease prevalence or virulence (Patrício et al. 2016). Hence the need to create a multi-
disciplinary approach where both the cause and effect should be addressed (Deem, 2015b). 
There are various areas that benefit from having a veterinarian, namely in wildlife capture 
and immobilization, in addressing wildlife health issues and in using them as sentinels to 
identify new diseases or epidemics of old diseases (Reading, Kenny, & Fitzgerald, 2013). 
Veterinary medicine uses the three role players (human, animal and environment) to assess 
health as a whole (one health concept). Veterinarians are able to realise that wildlife health, 
and subsequently, their conservation, is only able to flourish in healthy environments, and 
are able to help create them (Deem, 2015a). Additionally, if there is a disease that affects the 
health of endangered species, veterinarians are able to study its epidemiology, pathology 
and clinical implication. Furthermore, they must be educators and help spread the message 
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with regards to health continuum that exists within ecosystems that support biodiversity 
(Deem, 2015b). 
Through the combination of biomedical, ecological and veterinary sciences, we are able to 
explore the connections between ecological causes of changes in both animal and human 
health, to discover the environmental sources of pathogens and pollutants, and assess the 
consequences of diseases to wildlife populations (Aguirre et al., 2002). 
 
1.1.2. Conservation importance of sea turtles 
Our planet is currently contended to be in a new epoch, “Anthropocene”, which in other 
words signifies that humans are the drivers of the planets’ health. Humans have transformed 
over a third of the planet’s surface. We consume 35% of the products from the oceanic shelf 
and use 60% of the available freshwater each year. Furthermore, animal-based protein 
consumption is estimated to rise 50% yearly by 2020 (Pauly & Christensen, 1995; Postel, 
Daily, & Ehrlich, 1996; Rojstaczer, Sterling, & Moore, 2001; Vitousek, Ehrlich, Ehrlich, & 
Matson, 1986). This increased anthropogenic pressure has also impacted cross-species 
microbial mixing and exposure to new pathogens that further threatens species survival, 
including humans. The new “Anthropocene” era has led to a steady escalation of species 
extinction rates and to the reduction of the animal taxa (Deem, 2015a).  
There are seven living species of sea (or marine) turtles that are divided into two taxonomic 
families, the Dermochelyidae that contains the leatherback turtle, and the Cheloniidae that 
englobes the other six species (Poloczanska, Limpus, & Hays, 2009). According to the Red 
List of the International Union for the Conservation of Nature (IUCN Red List), the 
leatherback (Dermochelys coriacea), the loggerhead (Caretta caretta) and the olive ridley 
turtle (Lepidochelys olivacea) are classified as vulnerable, the green turtle (Chelonia mydas) 
is classified as endangered, and the hawksbill (Eretmochelys imbricata) and the kemp ridley 
turtles (Lepidochelys kempii) are critically endangered worldwide (Romero Zarco et al., 
2018), while the flatback turtle (Natator depressus) is classified as ‘data deficient’. 
The seven sea turtle species have roamed the Earth for at least 110 million years, when they 
became a distinct group from the other aquatic turtles (Paladino & Morreale, 2001). They are 
slow maturing animals built to last for many decades. Their unique body armour, which 
equips them with protection from their natural enemies, has not changed much since the time 
they swum the seas alongside the dinosaurs (Poloczanska et al., 2009).  
The conservation of sea turtles is fundamental due to their crucial link with the marine 
ecosystems. They have the capacity of transporting food from a productive system to a less 
fertile one. For example, they provide nutrients taken from the marine ecosystem to the 
coastal area through decomposing organic material (Reis & Goldberg, 2017). This process 
also occurs on the nesting beaches. Each reproductive female deposits hundreds of eggs 
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(approximately 500) during the nesting period containing high concentrations of energy. 
Some of these are  consumed by predators and detritivores that breakdown the organic 
material into simpler forms of energy (Bjorndal & Jackson, 2003; Bouchard & Bjorndal, 2008; 
Reis & Goldberg, 2017).  
Moreover, sea turtles also act as consumers, prey, competitors, predators and hosts to a 
diverse number of parasites and pathogens (Bjorndal & Jackson, 2003; Reis & Goldberg, 
2017). They are in  symbiosis with a large number of other species, such as, shrimp, 
remoras, the epibionts on their  carapace and filament algae (Reis & Goldberg, 2017).  
Besides help maintaining the health of the seagrass beds and coral reefs and other 
ecological functions, they have major cultural and tourist significance. Sea turtles have 
become the face of many conservation efforts worldwide. Whether they are used as a 
symbol for conservation or as a “marketing” strategy, they are able to draw attention from 
society and motivate people in favour of worldwide conservation (Frazier, 2005; Reis & 
Goldberg, 2017).  
 
1.1.3. Factors that affect the conservation of sea turtles 
Sea turtles were abundant animals in the tropical and temperate oceans until the 19th 
century, however, currently they suffer countless environmental pressures, mostly man-
made. The IUCN-Species Survival Commission Marine Turtle Specialist Group have recently 
classified the five major threats to sea turtles worldwide. They include fisheries bycatch, 
coastal development, pollution and pathogens, direct take and climate change (The State of 
the World’s Sea Turtles (SWOT), 2019).  
The fishing industry is estimated to kill thousands of sea turtles each year. Large commercial 
fisheries, such as long-liners and shrimp trawlers, catch numerous turtles as by-catch. Even 
though most are incidentally caught and thrown back to the sea, many suffer injuries or die 
as a result of swallowing hooks or becoming entangled in nets. This mass fishing also 
causes disruption to their food supply and habitat (Paladino & Morreale, 2001; SWOT, 2019).  
The sea turtle habitat is also being highly attacked. With shrinking coastlines, a rise in 
vehicles and ships traffic, artificial lighting and coastal pollution, the marine environment has 
suffered a huge degradation. This has direct impacts on the sea turtle nesting and foraging 
areas, causing a decline in population numbers (Reis & Goldberg, 2017; SWOT, 2019). 
Recent research also shows that climate change has affected sea turtles to an extent not 
known before. The rise in sea levels and high frequency of extreme weather events has 
destroyed some of the nesting beaches. Furthermore, temperature alterations have impacted 
the natural sex ratios of the hatchlings favouring female-biased ratios. Even the migratory 
patterns seem to have been altered (Reis & Goldberg, 2017; SWOT, 2019). 
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Historically, sea turtles are also victims of direct taking by humans. They are traded and 
killed all over the world. In the global market they may be used for their oil, leather, carapace 
to make jewellery and other luxury items, and for their meat and eggs ( SWOT, 2019).  
Lastly, the marine pollution is harming the sea turtles in many ways. Their nesting behaviour 
and hatchling orientation can be disrupted by light pollution (SWOT, 2019). In the sea, plastic 
pollution and discarded fishing gear, which turtles may ingest or get entangled in, petroleum 
by-products and other debris can affect their health and weaken their immune system, 
potentially leading to the rise of emerging infectious diseases (EIDs) and other health issues 
(SWOT, 2019) .  
Human-mediated climate change may also increase disease prevalence in the marine 
environment or cause deviations in host−pathogen relations and disease virulence (Patrício 
et al. 2016). Climate change causes stress to the marine life causing disruption in the normal 
ecosystem functions and exacerbating diseases (Cavicchioli et al., 2019). Many pathogens 
of marine taxa are sensible to temperature changes, and most host-pathogen systems are 
expected to experience more frequent or severe disease impacts with warming (Harvell et 
al., 2002). Rise in sea levels and temperature affect the spread and transport of pathogens 
as well as their replication. Additionally, selective harvesting of healthy individuals can 
increase FP prevalence in a sea turtle population (Stringell et al., 2015). 
 
1.1.4. Sea turtle conservation in Guinea-Bissau and Mauritania 
Sea turtles are large-scale migratory reptiles. They are able to travel hundreds or even 
thousands of kilometres between their nesting and feeding areas (Putman, 2018). In the 
shores of Africa, there are various sea turtle habitats with resident populations, as well as 
seasonal visitors or transients. Sea turtles that hatch in distant shores, such as South 
America, the Caribbean, and the Central Atlantic, may spend time in African waters 
(Monzón-Argüello et al., 2010), while hatchlings from coastal Africa may also cross the 
ocean to forage in the Americas (Patrício et al. 2017). This demonstrates the challenges that 
exist in understanding Africa’s sea turtles, due to the enormous scale and complexity of the 
task; they are among the least studied in the world.  
Guinea-Bissau, a small West African country, is known for its protected areas as part of the 
country’s efforts to maintain its biodiversity and conservation of protected species (Airaud, 
Regalla, Barbosa, & Betunde, 2016). In 2004, the Guinean government created the Institute 
of Biodiversity and Protected Areas (IBAP), an autonomous entity with the capacity of 
developing policies and regulations which aim to protect the environment and biodiversity. 
The IBAP implemented a National Action Plan for the Conservation of Sea Turtles, with 
admirable success, especially in the Bijagós Archipelago, just off the Guinea-Bissau coast. It 
is estimated that the green turtle nesting population at the Bijagós Archipelago is the third 
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largest in the Atlantic ocean and the sixth worldwide, with an average of 25,436 nests from 
2013 and 2014 (Patrício et al., 2017). Additionally, important foraging grounds have been 
identified in the archipelago, such as Unhocomo. The IBAP monitors and protects both 
nesting and foraging areas. 
Another major area in West Africa for green turtles is the Banc D’Arguin National Park 
(PNBA), in Mauritania. Established in 1976, its cold, nutrient-rich environment supports high 
levels of marine productivity and the main foraging area for the reproductive green turtles 
from the Bijagós Archipelago, they travel approximately a thousand kilometres from Guinea-
Bissau to Mauritania in order to eat (Godley et al., 2010). Many immature turtles also use the 
waters of the PNBA, their origin is still unknown, but most likely a great proportion origin at 
the large rookery in the Bijagós. The PNBA also harbours small numbers of nesting turtles, 
including green sea turtles and sporadically loggerheads (Hama et al., 2018). On the 29th of 
May, 1999 the Islamic Republic of Mauritania signed the “Memorandum of understanding 
concerning conservation measures for marine turtles of the Atlantic coast of Africa” by 
CMS/UNEP, giving the sea turtle national protected status (Mint Hama, Fretey, & Aksissou, 
2013).  
Reports show that in recent decades, the green turtle population has declined in many 
islands of the Bijagós Archipelago (Catry et al., 2009). The island of Poilão is currently the 
only site where numerous turtles still nest. This may be due to the fact that the island is 
considered sacred, combined with its remoteness and the fact that it is uninhabited. Very few 
men are allowed to enter the land, and even then, only during religious and social 
ceremonies, giving the island traditional protection. Thus, the sea turtles are not disturbed 
during the nesting season and their only threats on this particular island is climate change 
(Patrício et al. 2018), and the illegal fishing in the surrounding waters, even though it violates 
local prohibitions and national laws (Catry et al., 2002). At the coastal foraging grounds, both 
at the PNBA and in the Bijagós, there is not enough information to completely understand 
threats, but conflict with fisheries is known to occur, as well as intentional illegal harvesting. 
The presence of FP disease had not been assessed before the present study.  
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1.2. Sea turtles 
1.2.1. Chelonia mydas (Green sea turtle) 
The green sea turtle is the most abundant marine turtle in the West African coastal waters. 
Its carapace is green or dark greyish-green with four pairs of lateral plates. The adults can 
range in straight-line carapace length (SCL) from 80 to 120 cm, with marked geographical 
variation, and they can weight up to 200kg (Paladino & Morreale, 2001). Its head is small 
with a single pair of pre-frontal scales, four pairs of post-orbital scales and a serrated lower 
jaw, and the front appendages have a single claw as opposed to the hawksbill that has two 
(Figure 2) (Knöbl, Reiche, & Menão, 2011).  
 
Figure 2- Photo identification of a juvenile green sea turtle (original).  
 
Like other sea turtle species, the green sea turtle has a complex life-cycle with ontogenic 
habitat shifts. After emerging from their nest in the sand, the hatchlings disperse in the ocean 
and have an epipelagic life-style. This stage is referred to as the “lost years” for little is known 
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of their life during this period. During this oceanic stage they are omnivores, with more 
carnivorous tendencies. As they reach a certain size and become juveniles they recruit to 
coastal habitats, where they can remain for decades, and start feeding from the bottom 
(Patrício, Diez, & van Dam, 2014). They may graze on seagrass meadows, feed on 
macroalgae and even on small invertebrates (Reis & Goldberg, 2017). Due to the low 
nutritional value of this diet they have a slow growth rate (Baptistotte, 2007). As juvenile and 
adults they inhabit neritic shallow waters, typically up to 20 meters in depth, between the 
latitudes of 40ºN and 40ºS, where there is rich vegetation, and they are rarely seen in the 
open sea. The adult green turtles make cyclic migrations between the foraging areas and the 
nesting/reproductive area (Baptistotte, 2007). 
 
1.2.2. Viruses that affect sea turtles 
The global climate change that has arisen is documented to have increased the interactions 
among wildlife, domestic animals and humans. All this has resulted in the rise of EIDs. A 
number of diseases in wildlife species have been documented with direct links to species 
survival rates and in some cases, have led to their extinction. Some examples of infectious 
diseases with major impacts on wildlife populations are chytridiomycosis in amphibians, 
canine distemper in carnivores and fibropapillomatosis in sea turtles (Deem, 2015b). The 
latter of which shall be discussed further ahead. 
A number of pathogens and parasites have been documented to infect sea turtles. Two 
families of viruses (potentially six), 56 different species of bacteria, 15 species of fungi, six 
species of protozoa, 87 Platyhelminthes, six nematodes, four annelids and 17 arthropods 
(Alfaro, Koie, & Buchmann, 2006). 
There are two families of well documented viruses that infect marine chelonians, namely 
Herpesviridae and Papillomaviridae. However, there are another four families, which 
members are suspected to also infect sea turtles (Iridoviridae, Reoviridae, Retroviridae and 
Togaviridae). The lack of information regarding sea turtles in their natural habitat and the 
impossibility of experimental research due to their protected status conditions the advance in 
the knowledge on sea turtle diseases (Alfaro et al., 2006).  
All reptile herpesviruses are part of the subfamily Alphaherpesvirinae (McGeoch & Gatherer, 
2005). Currently, there are six herpesviruses that have been documented in chelonids, 
herpesvirus 1 to 6 (ChHV1 to ChHV6). ChHV1, ChHV5 and ChHV6 are described in marine 
turtles, whereas the rest are known to affect freshwater turtles. However, ChHV1 to ChHV4 
still have not been sequenced fully therefore are not recognised by the International 
Committee on Taxonomy of Viruses (ICTV) (Rodríguez, Duque, Steinberg, & Woodburn, 
2018). 
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These viruses infect both captive and free-ranging chelonians. In most of the research 
previously published it has been possible to isolate and sequence the virus, however due to 
the various diagnostic methodologies used and the inconsistency in the molecular follow-up it 
is difficult to proceed to the nomenclature of all the chelonian herpesvirus. Currently these 
are named Chelonid Herpesviruses, nevertheless, it is likely to change as more information 
becomes available, namely phylogenetic information (Rodríguez et al., 2018). 
Grey-patch disease is an infection that affects mostly captive sea turtles between the ages of 
56 days and 1 year old. A herpesvirus (Chelonid herpesvirus 1, ChHV1) has been identified 
as the causative agent of these epizootic skin lesions. These lesions begin as small circular 
papular lesions that eventually coalesce and form the characteristic patches. The more 
severe outbreaks of this epizootic disease appear in the summer where the high 
temperatures and over-crowding become a trigger for the reactivation of this herpesvirus 
(Jacobson, 2007).  
Another disease that mainly affects captive green sea turtles is lung, eye and trachea (LET) 
disease. The main characteristics of this disease are pneumonia and development of 
caseous material that cover the globes, cranial oral cavity, the glottis and the trachea. 
Clinical signs include an opened mouth of the individual and harsh respiratory sounds. 
Through transmission electron microscopy (TEM) a herpesvirus (Chelonid herpesvirus 6, 
ChHV6) was identified within the affected cells and later on confirmed by subsequent 
analyses to belong the subfamily Alphaherpesvirinae (Jacobson, 2007).  
The most studied infectious disease to afflict green sea turtles is fibropapillomatosis (FP) 
which has been linked to Chelonid herpesvirus 5 (ChHV5). 
 
1.3. Fibropapillomatosis  
1.3.1. History 
In 1938, Smith and Coates first described cutaneous papillomas, fibromas and 
fibropapillomas in a captive green turtle from the New York Aquarium, originally from Key 
West, Florida (Smith & Coates, 1938). Even though FP has been identified numerous times 
after, only in the 1980s did the disease reach epizootic proportions and now has been 
reported in every ocean (Herbst, 1994; Jones, Ariel, Burgess, & Read, 2016).   
After the first report of FP by Smith and Coates the estimated prevalence in the Florida Keys 
region was 1.5%, which rose to 20-60% in reports made in the 1980s. Subsequently, in the 
1990s the disease emerged in the Eastern Pacific, Hawaiian Archipelago, Indonesia and 
Australia, making the disease panzootic (Herbst & Klein, 1995; Herbst, 1994; Jones et al., 
2016).  
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1.3.2. Epidemiology 
Among free-ranging sea turtles, FP is mostly found in juveniles, following their migration and 
recruitment to shallow inshore waters, typically in tropical and sub-tropical areas (Jones et 
al., 2016). Sea turtles that inhabit inshore waters where there is a large anthropological 
concentration have higher prevalence than individuals that live in deeper open waters (Knöbl, 
Reiche, & Menão, 2011). 
Sub-adults and adults are also affected by FP, however in a lesser number (Herbst, 1994; 
Knöbl et al., 2011). Among juveniles, the disease is mostly observed in turtles with a 
carapace length of 40 to 60cm and between 10 and 30kg (Knöbl et al., 2011; Work & Balazs, 
1999).  
The possible explanation for this age differentiation may be that juveniles affected with FP 
either succumb to the disease or gain acquired immunity which, later on, gives them 
protection (Van Houtan, Hargrove, & Balazs, 2010). The facts that survival probabilities of 
juvenile aggregations do not seem to be affected by FP prevalence and that tumour 
regression has been observed in many sites, support the latter hypothesis (Patrício, Diez, 
Van Dam, & Godley, 2016). 
Herd immunity could also be a factor in FP prevalence in certain populations. Patrício et al. 
(2016) showed that in Puerto Manglar, after a large outbreak of FP epidemic, there was a 
high disease recovery rate. The fadeout of the disease could be due to the turtles becoming 
resistant to FP and therefore less individuals are susceptible to the disease (Lloyd-Smith et 
al., 2005). Epidemic cycles appear to depend on the recruitment of new individuals, naïve to 
FP, since affected turtle populations are able to recover over time (Patrício et al., 2016).  
Furthermore, there has not been any reports of FP in pelagic post hatchling (Herbst, 1994). 
There also is no significant difference in prevalence between male and female green turtles 
(Work, Balazs, Rameyer, & Morris, 2004).  
Even though the disease is more frequent in green turtles, it has been observed in most sea 
turtle species; C. caretta (Herbst, 1994), L. olivacea (Aguirre, Limpus, Spraker, & Balazs, 
1999), L. kempii (Harshbarger, 1991), E. imbricata (D’Amatto & Moraes-Neto, 2000) and D. 
coriacea (Huerta et al., 2002).  
Various studies conducted in Australia (Flint, Patterson-Kane, Limpus, & Mills, 2010), Puerto 
Rico (Patricio, Velez-Zuazo, Diez, Van Dam, & Sabat, 2011) and Florida (Hirama & Ehrhart, 
2007) suggest that FP does not affect the sea turtle population recovery or survival rates. 
The concern with FP is at an individual stand point. The tumours that form, although benign, 
may become fatal depending on their location, growth rate and degree of invasiveness. 
Therefore, understanding and monitoring this disease is a priority research area for sea turtle 
conservation for it is a threat to the survival of these  threatened species (Jones et al., 2016). 
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1.3.2.1. Aetiology 
Recently, molecular techniques, such as polymerase chain reaction (PCR) and in situ 
hybridization, have shown a strong statistical association between the Chelonid herpesvirus 
5 (ChHV5) and FP tumours, and this is now the main research area (Page-Karjian, 2019).   
The epizootic nature of FP led researchers to speculate that the disease was caused by an 
infectious agent. Herbst et al. (1995) were the first to successfully infect healthy animals with 
FP. In order to perform this, Herbst transferred cell-free lesion extracts, which were 
previously filtered through a 0.45µm syringe filter, from turtles that had tumours and 
inoculating it in a young captive turtle that was theoretically naïve to the disease. In three of 
the four experimental groups, all the turtles developed FP lesions, while the control animals 
that were housed in the facility under the same conditions did not develop the disease during 
the same study period. This information supports the speculation of an infectious agent that 
causes FP, namely a viral agent (Jones et al., 2016). 
There are a variety of viruses that are capable of inducing neoplasms such as the ones 
observed in FP. In consequence, some of them were investigated as potential aetiological 
agents, such as Papillomavirus (Herbst, 1994), papova-like virus (Lu et al., 2000), retrovirus 
(Casey et al., 1997) and herpesviruses (Jacobson et al., 1991; Quackenbush et al., 1998; 
Herbst et al., 1994, 2004). 
The biggest limitation to understanding the pathogenesis and aetiology of FP was the 
inability to grow ChHV5 in vitro (Herbst & Klein, 1995; Herbst, 1994; Work et al., 2009). 
Some studies attempted to grow the virus in fibroblasts or keratinocytes and were 
unsuccessful (Work, Dagenais, Balazs, Schettle, & Ackermann, 2015). This impasse is 
common to diseases in which the agent cannot be cultured in vitro, but are still known to be 
the causative agent, such as the herpes simplex and polio viruses (Alfaro-Núñez et al., 2016; 
Lipkin, 2009).  
However, a recent study (Work, Dagenais, Weatherby, Balazs, & Ackermann, 2017) was 
able to grow the virus in three-dimensional structures made from turtle skin, namely in skin 
biopsy specimens (plugs) and in organotypic cultures (rafts). This was the first instance this 
method was employed to grow a non-mammalian organism and of in vitro culture of ChHV5. 
These findings are crucial for the advancement of the confirmation of ChHV5 as the 
etiological agent of FP and help elucidate the epidemiology and transmission of the virus.  
Early molecular studies had concluded that while ChHV5 could be detected in lesions from 
skin biopsies, it was rarely detected in normal skin biopsies (Lackovich et al., 1999; 
Quackenbush et al., 1998). These results supported a strong correlation between the virus 
ChHV5 and the presence of FP (Jones et al., 2016). Quackenbush et al. (2001) successfully 
amplified ChHV5 from normal skin samples from turtle with FP lesions, implying furthermore 
the virus with the disease. These results could reflect an early or latent stage of the infection 
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and also proved that ChHV5 is more common than previously thought. Latency is a feature 
typical of herpesvirus, so such results were expected (Jones et al., 2016). Resembling other 
vertebrate herpesvirus, ChHV5 infections are estimated to be life-long and with high host 
specificity (Herbst et al., 2004; Page-Karjian et al., 2017). 
There are three lines of evidence that associate ChHV5 with being the primary etiological 
agent to cause FP. The first is that in every tumour analysed by PCR ChHV5 DNA has been 
yielded (Alfaro-Nuñez & Thomas, 2014; Herbst, Ene, Su, Desalle, & Lenz, 2004). The 
second line of evidence is that herpesvirus particles in FP infections have been observed 
using electron microscopy based on location, size and morphology (Jacobson, Buergelt, 
Williams, & Harris, 1991). Third, the successful experimental transmission of the disease to 
naïve FP green sea turtle by Herbst et al. (1995). 
More recently the presence of ChHV5 has been detected in turtles macroscopically FP-free, 
suggesting that the development of disease is not due to virus infection alone. Other factors 
should be considered, such as interaction host-pathogen-environment, host immunity, viral 
load and the severity of each variant. It is still to be determined whether FP lesions are the 
result of a single causal agent or if it is the result of multiple factors. However, it is clear that it 
is an infectious disease with strong links to ChHV5 (Jones et al., 2016). 
 
1.3.2.2. Environmental factors 
The surrounding environment is particularly important to marine turtles. They are animals 
that have a long-life span and a complex life history. During their lifetime, they travel 
thousands of kilometres and access a whole range of different habitats. However, once 
recruited into a near-shore foraging area, they tend to exhibit a high degree of site fidelity. 
This site fidelity means that the turtles persist in certain locations to feed even if the 
environment has suffered unfavourable changes. Any damage or destruction of the foraging 
areas may result in detrimental effects on the sea turtle population that inhabits them (Jones 
et al., 2016).  
Environmental factors may play a fundamental role in the multifactorial problem that leads to 
the development of FP. The chemical contaminants that are often disposed in the oceans 
degrading the quality of the water may act as immunotoxins or even cause cellular/genetic 
damage in turtles. They may also provoke disruption of the neuroendocrine function by 
indirectly disturbing the turtles’ immune system. Herbst (1994) showed that there was a 
positive correlation between the prevalence of FP in green sea turtles  and  near shore 
waters associated with agriculture, industry and urban development.  
Eutrophication of the oceans and invasive macroalgae may also be linked to high prevalence 
of FP (Van Houtan, Smith, Dailer, & Kawachi, 2014). The increase in nutrients in the 
environment, leads to an increment in the amount ingested by the green turtles. Arginine is of 
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particular significance as it is involved in cell inflammation, immune dysfunction, promoting 
viral tumours and is also known as biomarker for herpesvirus (Van Houtan et al., 2010).  Van 
Houtan et al. (2010) demonstrated how an increased intake of arginine could promote the 
herpesvirus and contribute to tumour formation.  Later, Van Houtan et al. (2014) 
demonstrated that FP prevails in eutrophic waters where turtle may consume large quantities 
of arginine. In this study it was estimated that the sea turtles increased they intake of arginine 
by 5 to 14 times (Van Houtan et al., 2014).  
Even though the mentioned studies show a strong correlation between the prevalence of FP 
in green sea turtles and areas where the quality of the water is degraded (Van Houtan et al. 
2010), it is difficult to identify one specific contaminate. The studies developed in the past 
focused on chemicals that persist in the environment or can bio-accumulate. However, the 
genetic damage may be a result of long-term exposure or from transient exposure. This 
means that future studies should be expanded to include all types of contaminants and the 
effects they may have on sea turtles. Nonetheless, the practicality of such investigations is 
daunting due to vastness of the marine environments  and the unknown possible causes of 
FP (Jones et al., 2016).  
The marine turtles can be sentinel indicators of marine ecosystem health (Aguirre et al, 
2004), due to their longevity and close proximity to inshore habitats. Since FP has been 
found to be associated with turtles exposed to poor water quality, disease monitoring may be 
a vital tool to assess the health of inshore marine habitats. Researching the epidemiology of 
this disease is mutually beneficial for marine turtles, other species in the ecosystem and 
humans alike (Jones et al., 2016).  
 
1.3.3. Phylogeographical analysis 
The ChHV5 is a linear double stranded DNA virus, enveloped with icosahedral capsid, T=16 
symmetry and a diameter about 150-200nm. Phylogenetic analysis of the ChHV5 genes 
revealed that the virus aligns closely with other members of the Alphaherpesvirinae 
subfamily, but in a separate category. Davison and McGeoch (2010) amplified and 
sequenced the single-stranded DNA-binding protein (UL29), glycoprotein B (UL27), DNA 
polymerase (UL30) and two subunits of the DNA packaging terminase (UL28 and UL31). 
Following the sequencing, the results were aligned and analysed using the Bayesian 
phylogenetic program. The resulting phylogenetic tree showed that ChHV5 exists as an out-
group which is clearly separate from the current genera (Jones et al., 2016). This led to the 
proposal of the virus being placed in its own genus, and in 2012, ChHV5 was placed in a 
newly erected genus, Scutavirus, of the subfamily Alphaherpesvirinae of the Herpesviridae 
family (Adams & Carstens, 2012). To this date, approximately 132kbp of the virus has been 
sequenced (Ackermann et al., 2012; Cárdenas et al., 2019). 
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The ChHV5 has been identified in various locations around the world and geographic 
variations have been identified, through alignment of partial genes. Patrício et al. (2012) 
identified four phylogeographical groups of ChHV5: eastern Pacific, western Atlantic/eastern 
Caribbean, mid-west Pacific and Atlantic. The study revealed that between nearby foraging 
ground the viral variant is similar, whereas the variants are considerably divergent between 
distant foraging regions.  
Studies about the co-evolution of virus and the host (Herbst et al., 2004) demonstrated that 
the virus diverged prior to the separation of avian and mammalian alphaherpesvirus. ChHV5 
became specific to marine turtles approximately 300 million years ago (mya) and the two 
most divergent phylogeographical groups separated approximately 1.6-4.0 mya. Patrício et 
al. (2012) estimated that the most recent common ancestor of the currently known variants 
existed 193-430 years ago. Both studies show that the ChHV5 has evolved with the marine 
turtles and that it has undergone region specific co-evolution with its host. Although more 
research is needed on the matter to resolve the time of divergence, these studies conclude 
that the virus is not new nor is it a recent mutation of an old virus. The recent panzootic 
outbreaks are most likely due to environment factors and modern day anthropological 
activities (Jones et al., 2016).  
1.3.4. Transmission 
The transmission route of the FP disease is still uncertain. It has not been observed in 
pelagic juveniles, which has led to the suspicion of horizontal transmission when the turtles 
recruit to the neritic zone. The sea turtles potentially experience various stressors with the 
change of habitats, including long migrations, adaption to a new environment, changes in 
population density, changes in diet, and pathogen exposure. These may contribute to a 
depression in the individuals’ immune system and make them more susceptible to infection 
with ChHV5 and to the development of FP lesions. There is also the possibility that these 
stressors reactivate a latent ChHV5 infection and of direct transmission of the virus between 
co-habiting turtle during mating and aggression (Jones et al., 2016).  
The virus is mostly likely shed in the skin of the sea turtles. Work et al. (2015) linked, for the 
first time, a capsid protein (F-VP26) to epidermal intranuclear inclusions (EIIs) that contained 
herpesvirus-like particles (Figure 3).  
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Figure 3- Epidermal skin cell from a fibropapilloma of a green turtle with intranuclear 
inclusions (arrow). Image by (Work, Dagenais, Balazs, Schettle, & Ackermann, 
2015).   
 
This reveals a possible location of active replication of the ChHV5 and a viable route of viral 
transmission. However, the study showed that viral shedding via epithelia was sporadic yet 
followed an exponential distribution. This means that there may be a few individuals that are 
responsible for intense viral shedding, called superspreaders (Work et al. 2015).  
The fact that virus variants are similar within regions may be reflecting the fidelity behaviour 
that sea turtles tend to demonstrate to their foraging site.  Such behaviour could be a key 
factor limiting the spread of FP among foraging grounds, if highly infectious individuals 
responsible for disease transmission stay resident (Patrício et al. 2016). 
Other means of transmission of FP have also been studied. Some of the proposed 
mechanisms include transmission via virus-laden seawater, through cleaner fishes that bite 
the tumours (Yuanan Lu, Yu, Zamzow, & Al., 2000), and  transmission via  vectors , namely, 
the marine leech (Ozobranchus spp.). The leech when analysed contained significantly high 
viral loads, becoming the most likely candidate for a mechanical vector of ChHV5 (Greenblatt 
et al., 2004). However, their role has not been confirmed as for other details of the virus still 
have not been explained, such as the possible latent state of the virus and the involvement of 
other co-factors in disease expression of FP (Jones et al., 2016).  
 
1.3.5. Clinical signs, diagnostic and treatment 
FP tumours are normally easy to visualize. They can occur on any soft part of the body and 
have a wide number of appearances, thus any sign of a proliferative mass should be 
suspected of being FP. They appear as flat plaques, pedunculated, sessile, verrucous, 
smooth, polypoid nodules or a combination of multiples types (Page-Karjian, 2019). 
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Histologically, the tumours display papillary epidermal hyperplasia supported by broad 
fibrovascular projections with a varying ratio of epidermal to dermal proliferation (Figure 4) 
(Page-Karjian, 2019).   
 
Figure 4- Histological image of the epidermal layer of a fibropapilloma. Image from 
(Duarte et al., 2012).  
 
The tumours can be associated with myxofibromas, fibrosarcomas, papillomas, fibromas and 
fibropapillomas, where the latter is the intermediate phase of the lesion development and the 
other lesions are linked with other stages. In the early stage of development papilloma 
lesions are found whereas in the chronic phase the predominant lesion are fibromas, with 
proliferation of the dermal layer, whilst the epidermal layer remains normal (Herbst, 1994; 
Kang et al, 2008; Jones, Ariel, Burgess, & Read, 2016).  
Occasionally, around the margins of the tumours, lymphocytes and macrophages may be 
found in moderate to large number. In some cases there is histologic evidence of tumour 
regression (Page-Karjian, 2019). 
When an individual is infected the initial stage may either result in clinical disease or remain 
subclinical. It is likely that following this period there is an established latent infection in 
certain tissues, similar to other herpesviruses (Herbst et al., 1995; Work, Dagenais, Balazs, 
Schettle, & Ackermann, 2015). Herbst et al. (2008) demonstrated that there was a high 
prevalence (70-80%) of ChHV5 specific antibody reactivity in green sea turtle populations 
known to have had FP (prevalence’s from 0% to 50%), showing that infection with ChHV5 
does not necessarily overt to disease (Page-Karjian et al., 2017).  
Animals with severe cases of FP are often found stranded on the beach in debilitated form 
and cachectic. These animals often are anaemic, with leukopenia, lymphopenia, 
eosinopenia, heterophilia, hypoproteinaemia, hypocalcaemia, hypoalbuminemia and 
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hyperglobulinemia. These clinical pathology findings are compatible to animals with chronic 
diseases and repeated antigenic stimulation (Page-Karjian, 2019). 
FP is of pressing concern especially since animals affected with severe FP have poor 
prognosis. Their feeble general health makes them prone to secondary or opportunistic 
infections. Fibropapillomas are often found on the skin, the ocular and oral region, the 
flippers and in extreme cases the internal organs. This may bring difficulties in sight, feeding, 
swimming and cause internal pressure which may culminate in organ dysfunction and/or 
physiologic imbalances (Page-Karjian, 2019).  
Cutaneous FP lesions are relatively easy to identify, however definitive diagnosis require 
laboratorial techniques for confirmation. Histopathology findings compatible with FP lesions 
and a follow-up diagnosis using molecular techniques, such as PCR, in situ hybridization or 
immunohistochemistry, are recommended to reach a definitive diagnosis of FP. If possible, 
imaging such as radiography, ultrasonography, computed tomography (CT) or magnetic 
resonance imaging (MRI) should be used to rule out visceral tumours, although in most case 
this is not possible (Page-Karjian, 2019).  
For identification of viral DNA most biological swabs (oral, cloacal and ocular swabs) may be 
used, however they are not as sensitive as tumour and skin biopsies for ChHV5 DNA 
detection (Monezi et al., 2016).  
When treating FP afflicted animals, supportive care is essential. The animals’ overall health 
strongly affects the outcome of the treatment. Even though there is lack of evidence that 
immunosuppression is needed for FP to develop, there is evidence that the disease does 
lead to immunosuppression (Work, Rameyer, Balazs, Cray, & Chang, 2001), meaning 
boosting the  immune system and avoiding stressful situations are important to try impede 
viral reactivation. Supportive care of the turtles includes adequate water, fluid therapy, pain 
management and treating secondary infections (Page-Karjian, 2019).   
To treat the cutaneous tumours these should be surgically removed. Some evidence 
suggests that less severe FP lesion may spontaneously regress, however this should not be 
expected in most cases. Local or general anaesthesia should be administered with the 
adequate monitoring. Carbon dioxide (CO2) laser-mediated tumour removal is the most 
common technique used. This method allows for minimal haemorrhage around the removal 
site as it also cauterizes and seal the wound while it cuts the tissue. Laser power, pulse rate 
and hand piece size may vary according to the surface area and depth of the tumour. In most 
cases sutures are not necessarily, the excision may be left open to heal by secondary 
intention.  
Recently, electrochemotherapy has been presented as an alternative to the traditional 
techniques. This procedure is effective and safe, presenting complete remission in the turtles 
used for the study. The use of bleomycin (genotoxic drug) together with the surgery is 
advantageous as it permits longer intervals between treatments, which means less 
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manipulation and stress for the turtle (Brunner, Dutra, Silva, Silveira, & Monteiro Martins, 
2014).  
Pre-operative care should include analgesics and antibiotics. In the postoperative monitoring 
the individual should be dry-docked for up to 24 hours and there should be a careful vigilance 
of its recovery. The cutaneous wounds can take as little as 12 weeks to heal. However, 
regrowth of removed tumours may occur. One study found that 38.5% of green sea turtles 
experienced tumour regrowth an average of 36 days post-surgery. To prevent regrown 
tumours a wide margin of skin should be excised during the surgery whenever possible as 
the normal skin cells may be a source of ChHV5. Lowering the water temperatures in the 
tank by 2-5ºC may also help prevent viral reactivation (Page-Karjian, 2019).  
Lastly, this disease should be considered zoonotic, so the appropriate biosecurity measures 
should be taken when handling the marine turtles in both field and captive situations.   
 
 
 
 
1.4. Conclusions 
There are many lacunas to be filled in the knowledge of FP disease, mainly as the 
aetiological agent of FP is still unconfirmed. It is fundamental to understand how ChHV5 is 
transmitted between turtles and between different regions. A useful tool for this research is 
molecular epidemiology, which infers the genetic differences in the virus between geographic 
areas. It also helps to uncover possible relationships between host lineage and viral strains, 
as well as the genes likely responsible for pathogenesis and viral replication. The molecular 
investigations on the virus will help improve the studies on epidemiology and pathogenesis 
(Jones et al., 2016). 
Geographically, there are major information gaps, which is particularly true for West Africa 
sea turtles. To date there are limited reports of FP in the region (Duarte et al., 2012; Formia 
et al., 2007). Baseline information on FP and ChHV5 presence and prevalence are virtually 
inexistent and there is no knowledge on which life-stages are more afflicted or if infection is 
ubiquitous. Also, there is no monitoring program in place to assess disease prevalence in the 
long-term. Assessing key foraging grounds for the green sea turtle in West Africa will 
contribute to fill-in this knowledge gap and aid the conservation of this charismatic and 
vulnerable species.   
 
1.4.1. The objective of the study 
Given the current information on the green sea turtles of West Africa, this thesis aims to 
study aspects related to FP disease among feeding aggregations from the region. This study 
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was conducted in collaboration with the Instituto da Biodiversidade e Áreas Protegidas 
(IBAP) of Guinea-Bissau, the Parc National du Banc d’Arguin (PNBA) in Mauritania and the 
ISPA – Instituto Universitário, in partnership with the MAVA Foundation.  
In order to support the conservation efforts made by these institutes and worldwide, this 
study on FP was conducted to better understand the Chelonia mydas population in West 
Africa, namely Guinea-Bissau and Mauritania (Figure 5). The objectives of this thesis are a) 
to detect and quantify the infection by Chelonid Herpesvirus 5 (ChHV5) in the skin of both 
healthy and afflicted green sea turtles, from Guinea-Bissau and Mauritania; b) to estimate the 
prevalence of FP in each geographic site; c) to establish a relationship between the 
macroscopic lesion pattern of FP and the viral charges of ChHV5; d) to assess which class-
size is more affected, and e) to conduct a phylogenetic analysis of the viral strain variants 
with regards to the ChHV5 strains obtained at a global level. 
 
 
 
 
 
Figure 5- Juvenile green sea turtle with fibropapillomas in the right shoulder (Photo: R. 
Patrício). 
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Figure 6- A work-flow diagram of the structure of Section 2- Materials and Methods.  
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2. MATERIALS AND METHODS (Figure 6) 
2.1. Sample origin  
All samples included in this study were obtained from green sea turtles (Chelonia mydas) 
from the south of the National park of Banc D’Arguin in Mauritania (PNBA, N19.582373º, 
W16.423635º) shown in Figure 7, and the westernmost islands of the Bijagós Archipelago in 
Guinea-Bissau, Unhocomo and Unhocomozinho (N11.3129º, W16.40279º) shown in Figure 
8.  
Three separate missions were held on the islands of Unhocomo and Unhocomozinho in 
Guinea-Bissau. The first was held between the 18th of March and the 22nd of March 2018, 
and eleven turtles were captured (eight juveniles, two sub-adults and one adult). The second 
took place from the 21st of October 2018 until the 25th of October 2018 with fifteen individuals 
caught (eleven juveniles, two sub-adults and two adults). On the third fieldtrip, held from the 
25th until the 28th of March 2019, ten individuals were caught (8 juveniles, 1 sub-adult and 1 
adult). At the PNBA two fieldtrips were conducted on the 8th of May 2018 and between the 5th 
and 8th of March 2019, resulting in 73 captured turtles (1 adult, 16 sub-adults and 56 
juveniles). In total 109 green turtles were captured.  
 
Figure 7- Satellite map of Mauritania. Right figure- localization of the National Park Banc 
D’Arguin in Mauritania (source: 
https://www.google.com/maps/place/Parc+National+du+Banc+D'Arguin/).  
 
Figure 8- Satellite map of Guinea-Bissau. Right figure- localization of the Islands of 
Unhocomo and Unhocomozinho (source: 
https://www.google.com/maps/place/Unhacomo/).  
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2.2. Collection of the samples 
The animals were caught using a fish net and then brought onto the boat for processing. At 
the site of each capture, the time, the location with geographic positioning system (GPS) and 
the height of the tide were registered. For each animal, an identification photo was taken, 
and the curved carapace length (CCL), the curved carapace width (CCW), the tail length 
were measured with a flexible measuring tape to the nearest 0.1cm.  
At the Guinea-Bissau site, for further identification of the turtles, both flipper tags and passive 
integrated transponder tags (PIT tags) were implanted and registered accordingly. This was 
not conducted at the PNBA, Mauritania, as a monitoring protocol is not yet established for 
that site. 
After a visual assessment of the animals’ general health, the collection of samples was 
carried out. Gloves were worn by the handlers and all the instruments used were sterilized 
with chlorhexidine. The area of the skin chosen for the biopsy was previously disinfected with 
a diluted povidone-iodine solution. Then, an approximately 0.5 square centimetre sample of 
skin was collected using a scalpel from the right shoulder and stored in a vial containing 90% 
alcohol. Normal skin tissue was collected from all individuals. Animals that presented 
macroscopic fibropapillomatosis-like tumours were biopsied and the collected tissue was 
preserved in vials with 90% alcohol due to inaccessibility to any freezing-methods. 
All animals were handled according to “The Universal Declaration on Animal Welfare” (World 
Society for the Protection of Animals, 2007) and released at the end of the procedure. 
In total, 76 normal skin biopsies were collected; 36 from turtles foraging around Unhocomo 
and Unhocomozinho, and 40 samples from turtles foraging in the Banc D’Arguin. A total of 
28 tumour biopsies were also collected; 13 from Unhocomo/Unhocomozinho and 15 from the 
Banc D’Arguin.  
 
2.3. Nucleic acid extraction 
To extract and purify total DNA from the sea turtles’ samples, the DNeasy Blood & Tissue kit 
(Qiagen, Hilden, Germany) was used following the protocol recommended for animal tissues 
(Spin-Column protocol).  
At the laboratory, the hydrated samples were cut into fragments of 25mg and placed in 
microcentrifuge tubes. A volume of 180µL Buffer ATL and then 20µL of proteinase K was 
added to each tube. Buffer ATL contains SDS sodium hydroxide (NaOH) which provokes the 
lysis of the cells. SDS solubilizes the cell membrane, releasing the content within, while 
proteinase K digests the proteins including nucleases. The tubes were placed in the vortex 
for a thorough mixture and incubated at 56ºC until lysis was complete. Then 200µL of Buffer 
AL was added to the sample, which was vortexed, and had an additional 200µL of ethanol 
100% added. Buffer AL contains chaotropic salts which allows the DNA to bind to silica 
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beads in the DNeasy Mini column (DNeasy Blood & Tissue Handbook, 2006).  
The entire mixture was transferred into the DNeasy Mini column, previously placed in a 2mL 
collection tube. The tubes were centrifuged (Eppendorf 5415R) at 7000 rotations per minute 
(rpm) for one minute and the flow-through was discarded. The centrifugation allows for the 
binding of the DNA to the silica beads in the membrane due to the presence of the 
chaotropic salts (high ionic strength) and the removal of any contaminants. Afterwards, the 
columns were placed in another collection tube and 500µL of Buffer AW1 was added to 
each. The columns were centrifuged for one minute at 7000rpm, and the flow-through 
discarded. The last step was repeated with AW2 Buffer and then centrifuged for three 
minutes at 14000rpm to dry the DNeasy membrane. These two wash steps remove any 
remaining contaminants and enzyme inhibitors from the silica membrane. Finally, 200µL of 
Buffer AE was pipetted directly on the membrane, incubated at room temperature for one 
minute and centrifuged at 7000rpm for one minute to elute the DNA. The low ionic strength of 
the Buffer AE allows the DNA to elute through the column into the new tube (DNeasy Blood 
& Tissue Handbook, 2006). 
A small set of samples were homogenised with phosphate buffered saline (PBS) and clarified 
at 3000g for 5min. Total DNA and RNA were extracted from 200μL of the clarified 
supernatants, using the MagAttract 96 cador Pathogen Kit in a BioSprint 96 nucleic acid 
extractor (Qiagen, Hilden, Germany), according to the manufacturer’s protocol. DNA samples 
were kept at -20ºC until use. 
 
2.4. Preparation of competent cells 
A small sample of pGEM-T1(1) DNA plasmid recombinant was received for the present study 
to be used as a positive control in the conventional PCR assays and to validate a qPCR 
developed by Quackenbush et al. (2001). This recombinant DNA was obtained in a previous 
study on FP, and its nucleotide sequence is available in GenBank 
(https://www.ncbi.nlm.nih.gov/genbank/) under the accession number HM348895.1 (Duarte 
et al., 2012).  
To produce enough quantity of recombinant DNA (pGEM-T1(1)) for the purposes of this 
work, Escherichia coli competent cells were prepared, transformed, cultured in solid media, 
picked and grown in a Luria-Bertani (LB) broth, from which plasmid DNA was purified using 
the boiling method and, later on, purified by the QIAGEN Plasmid Midi Kit (Qiagen, Hilden, 
Germany) and quantified.   
The cells used for this procedure were DH5-α, an engineered strain of E. coli (Chromosomal 
Genotype fhuA2 lac(del)U169 phoA glnV44 Φ80' lacZ(del)M15 gyrA96 recA1 relA1 endA1 
thi-1 hsdR17). 
For the preparation of competent cells, firstly LB broth plates were prepared. LB is a nutrient-
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rich media that permits the nutrition of the bacteria and with the incorporation of agar we 
create a solid medium on which the bacteria cannot digest the agar but are able to grow on 
top of it due to the LB (Liu & Usinger, 2019).  This particular strain of E. coli bacteria does not 
contain any inherent resistant to antibiotics so for the culture no antibiotics were added to the 
plates. Using a sterile inoculating loop, a portion of the frozen pre-inoculum was scraped and 
streaked onto the LB plate. These plates were then placed upside down in an incubator at 
37ºC overnight.  
Next, a single colony was picked into 5mL of liquid LB medium and once again incubated 
overnight at 37ºC with shaking at 225rpm (Infors HT CH-4103 Incubator). 
On the third day, 100µL of the culture was inoculated in each of the two flasks containing 
10mL of LB and again incubated at 37ºC at 225 rpm for roughly two to three hours to ensure 
the exponential growth of the bacteria.  
The optic density (OD) was measured each 30 min, using a spectrophotometer which lies on 
the principle of absorbance/transmission of light to verify the phase of the growth curve of the 
culture. As the light is pointed at the culture it is scattered and less light is received by the 
detector. This turbidity is directly proportional to the number of cells present in the culture. 
The bacteria reach the optimal growth stage (exponential stage) when the OD reaches 0.4 
(Godbey, 2014).  
When the optical density reached 0.4OD, the culture was taken out of the incubator and 
placed in an ice bath for ten minutes. Afterwards, it was centrifuged at 6000rpm (Eppendorf 
5415R) for five minutes at 4ºC. When this operation was completed, calcium chloride (CaCl2) 
was added to the cells for the transformation. Then, 1mL of the inoculate was suspended in 
2mL of filtered TSS (0.03g of MgCl2, 0.3g of PEG8000, 150µL of DMSO and 2.85mL of LB). 
After ten minutes of incubation on ice, the culture was divided into vials and stored at -80ºC.  
 
2.5. Transformation of the E. coli DH5-α cells with pGEM-T1(1) 
The transformation of the competent cells ensures the plasmid vector is transferred into the 
bacteria as an extrachromosomal DNA. 
First, a LB with agar plate was prepared with 100µg/mL of ampicillin for the growth of the 
transformed cells. Only transformed E. coli cells will be able to grow in ampicillin 
supplemented medium due to the resistance conferred by the plasmid to this antibiotic. 
However, if present in the original plasmid DNA preparation, re-circularized DNA (without the 
insert) would also confer the ability of the transformed cell to grow. Therefore, in order to 
select bacteria containing the insert of interest, a selectable marker is use.  
A vial containing 25µL of frozen E. coli DH5-α was thawed on ice. Then, 2µL of recombinant 
DNA was pipetted into this vial and incubated for 30 minutes on ice. A heat shock was given 
to the cells in order to alter the membrane permeability and allow the recombinant DNA to be 
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up taken by the bacteria. Next, 250µL of S.O.C. medium was added to the vial and placed in 
an incubator at 37ºC and 225rpm for one hour (Infors HT CH-4103 Incubator). After the given 
time, the content of the vial was spread onto a LB-agar plate containing 40µL of X-Gal, 
100µL/mL ampicillin and 40µL isopropyl β-D-1-thiogalactopyranosidae (IPTG) and incubated 
overnight at 37ºC. 
 
2.6. Extraction and purification of recombinant DNA pGEM-T1(1)  
Recombinant plasmid DNA was extract from six isolated colonies by the boiling method to be 
subsequently hydrolysed and sequenced. One was selected to be produced in larger scale 
using the QIAGEN Plasmid Midi Kit were used.  
Each white colony grown in the LB agar plate was picked and placed in a flask containing 
10mL of liquid LB. The flask was placed in an Infors HT CH-4103 Incubator overnight, at 
37ºC and 225rpm.  
Afterwards, 2mL of the culture was transferred into an Eppendorf tube and centrifuged at 
11000rpm for 20 seconds. The supernatant was discarded and this step repeated twice 
more. The pellet formed was suspended with 750µL of STET buffer [8% sucrose, 50mM Tris-
HCL (pH 8.0), 50mM EDTA (pH 8.0), 5% Triton X-100], 60µL of lysozyme and 30µL of 
Rnase. The plasmid DNA has a smaller size than the chromosomal DNA, which allows for 
the plasmid DNA to be removed without releasing the remaining chromosomal DNA. 
Lysozyme is an enzyme which enables the breakdown of the bacterial wall. The STET buffer 
contains sucrose, a substance which helps maintain the osmotic pressure within while 
preventing the collapse of the cell wall (“Key steps in plasmid purification protocols,” 2013). 
The tube was then placed in boiling water (100ºC) for 4 minutes and immediately placed after 
in ice for 5 minutes. This allows the denaturing of the chromosomal DNA and proteins 
contained within the bacteria. The plasmid DNA is also affected, with the breakdown of the 
hydrogens bonds, however due to its supercoiled form it is able to remain intact (“Key steps 
in the plasmid purification protocols”, 2013).  
Following this step, the tube was subjected to centrifugation at 11000rpm for 15 minutes 
(Kubota KR-2000C). After the centrifugation a bacterial pellet containing cell debris and 
protein is formed while the plasmid DNA remains in the supernatant. This supernatant was 
carefully verted into a new Eppendorf tube with equal volume of isopropanol added and 
placed at -20ºC for 30 minutes. The isopropanol allows for the precipitation of the DNA. The 
tube was centrifuged at 11000rpm (Kubota KR-2000C), and then put at 4ºC for 20 minutes to 
prevent overheating. A pellet was formed containing DNA which was washed with ethanol 
70% then air-dried. The DNA was then dissolved with 50µL of RNase free water (“Key steps 
in the plasmid purification protocols”, 2013) and stored a -20ºC.  
In order to produce a high yield of pure plasmid DNA (pGEM T1(1)) the QIAGEN Plasmid 
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Midi Kit was also used.  In this case, 50µL of the original culture was transferred into an 
Erlenmeyer flask containing 25mL of LB medium and incubated overnight in the Infors HT 
CH-4103 Incubator at 37ºC and 225rpm. Next, the culture was centrifuged at 7000rpm 
(Eppendorf 5415R) for 15 minutes at 4ºC. A cell pellet was formed and the supernatant was 
discarded. To the pellet 4mL of Buffer P1 was added to harvest and re-suspend the pellet.  
Then, 4mL of Buffer P2 was added and incubated to room temperature for 5 minutes. Buffer 
P2 contains SDS sodium hydroxide (NaOH) which provokes the lysis of the bacterial cells. 
SDS solubilizes the cell membrane, releasing the content within, while NaOH denatures the 
chromosomal and plasmid DNA as well as the proteins. In optimal conditions, this step 
allows for the plasmid DNA to be released from the cells without releasing the cell wall-bound 
chromosomal DNA, and also minimizes the time plasmid DNA is exposed to the denaturing 
conditions (“Key steps in the plasmid purification protocols”, 2013). 
Following this step, 4mL of Buffer P3 was added and the mixture was incubated on ice for 15 
minutes. This buffer neutralizes the lysis using acidic potassium acetate, a high salt solution 
that after precipitation retains denatured proteins, chromosomal DNA and cell debris.  
The sample was centrifuged at 12900rpm (Kubota KR-2000C) for 30 minutes at 4ºC. The 
consequent pellet formed contained the unwanted cellular debris and the supernatant 
contained all the plasmid DNA. The supernatant was centrifuged again to certify the 
elimination of any remaining proteins or chromosomal fragments.  
The supernatant was then loaded onto a QIAGEN-tip and filtered by gravity flow. The resin 
within the QIAGEN-tip ensured that only the plasmid DNA binds, while the debris passed into 
the flow-through fraction. Buffer QC was then added to the QIAGEN-tip to remove any 
remaining contaminants.   
To elute the plasmid DNA contained in the resin, Buffer QF was pipetted to the QIAGEN-tip 
and the solution was collected in a tube. This eluted DNA was then desalted and 
concentrated by isopropanol precipitation. After the centrifugation, the pellet was washed 
with 70% ethanol to remove any residual salt. The pellet was finally air-dried, re-dissolved 
using 50µL of water and stored at -20ºC.   
 
2.7. Quantification and purity evaluation of pGEM-T1(1)  
The quantification of the resulting DNA extraction was performed using the NanoDrop™ 2000 
spectrophotometer. It permits determination of the quantity of nucleic acid in nanograms per 
microliter (ng/L). Nucleic acid and proteins attain maximum light absorbance at 260nm 
(nanometres) and 280nm, respectively. The ratio of the maximum absorbance in relation to 
the 280nm absorbance is used as measure of the purity of the DNA extracted. In general, 
values close to 1.8 is accepted as “pure” for DNA samples. The absorbance at 230nm is 
considered as being the result of other contamination (e.g. by sugars), therefore the 260/230 
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is also calculated. The expected 260/230 value is between 2.00-2.2. (Matlock, 2015).  
2.8. Analysis of recombinant DNA by restriction enzyme hydrolysis 
In order to verify that the bacterial colony incorporated correctly the intended insert, the 
recombinant plasmid amplicon was extracted and subjected to enzymatic restriction. 
Plasmids are circular, double-stranded DNA molecules that replicate separately from a cell’s 
chromosomal DNA. A restriction enzyme is an enzyme that recognizes specific sequences 
(usually 4 to 6 bp long and palindromes) in dsDNA molecule called restriction sites and 
cleaves both DNA strands at vicinity of these sites, generating cohesive or blunt ends. They 
occur naturally in bacteria and are used as a defence mechanism against invading 
organisms’ DNA. The restriction enzyme used for the p-GEM T easy vector were Sac II and 
Spe I. The insert is cloned into the multiple cloning site (MCS) of the plasmid (Figure 9). 
These restriction sites are found on either side of the insert location. If the reaction is 
successful, the enzymes cleave the insert on either side producing a linear DNA strand that 
later can be visualized through agarose gel electrophoresis.  
  
Figure 9- Visual representation of the pGEM-T Easy vector multi-cloning site. The sites 
SpeI and SacII are underlined (source: https://www.promega.com/-
/media/files/resources/protocols/technical-manuals/0/pgem-t-and-pgem-t-easy-vector-
systems-protocol.pdf).  
 
To perform this restriction, 3µL of the recombinant DNA (0,5-1µg of DNA), 1µL of each 
enzyme (10.000U/L), 3µL of Buffer 10x and 23µL of water were mixed in a tube and 
incubated at 37ºC for two hours. The digestion products were visualised as described in 
section 3.3.3- Results. 
 
2.9. Sequencing analysis (Sanger method) 
The recombinant DNA pGEM-T1(1) was subjected to nucleotide sequencing to confirm the 
sequence of the insert was the desired ChHV5 selected gene sequence. Sequencing was 
performed with the ABI Prism BigDye Terminator v3.1 Cycle sequencing kit on a 3130 
Genetic Analyser (Applied Biosystems, Foster City, CA, U.S.A) using two commercial 
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primers (M13 forward and reverse) for the vector MCS flanking sequences.  
The DNA template was prepared from the purified plasmid DNA. To perform the cycle 
sequencing the following components were added: 2µL of BigDye Terminator Ready 
Reaction Mix, 2µL of M13 forward primer, 1µL of M13 reverse primer, 3µL of DNase-free 
water and 3µL (0,25 µg) of the plasmid DNA. The tube was placed in the thermocycler with 
the following amplification protocol: 1 minute at 96ºC for denaturation and 25 cycles of 10 
second denaturation (at 96ºC), 5 seconds for hybridization (at 50ºC) and 1 minute for 
elongation (at 60ºC). 
The sequencing reaction was later purified using ethanol and sodium acetate precipitation. 
Accordingly, 2µL of 125mM EDTA, 2µL of 3M NaAc and 50µL of EtOH 95% were pipetted 
into the mixture and placed at -20ºC for 30 minutes. Then, it was centrifuged for 20 minutes 
at 15000rpm (4ºC). From the tubes, the supernatant is carefully aspirated and 170µL of 
EtOH 70% placed inside. Once again the mixture was centrifuged for 10 minutes. The 
supernatant was removed and the pellet dried. To dissolve the pellet, 20µL of formamide was 
added, prior reading. 
 
2.10. Real-time polymerase chain reaction (qPCR) conditions 
The PCR amplification was performed using the CFX96™ Optical Reaction Module (Bio-Rad).  
The reaction volume was 20µL containing 0.5µL of turtle pol probe (50pmol/µL), 0.5µL of 
Tartaruga RT Forward primer (50pmol/µL), 0.5µL of Tartaruga TR Reverse primer 
(50pmol/µL), 10µL of SensiFAST Probe Hi-RoxMix 2x (Bioline Reagents Ltd., United 
Kingdom), 3.5µL of Rnase-free water and 5µL of the DNA template. These PCR mixtures 
were subjected to the following amplification cycles: 10 minutes at 95ºC to activate the Taq 
polymerase, then 45 cycles of denaturation 15 seconds at 90º and elongation 1 minute at 
60ºC.  
At the end of each PCR elongation step the amount of fluorescence emitted and the 
threshold cycle (Ct) value were registered. Ct values above or equal to 38 were considered 
negative. 
 
2.11. qPCR validation 
2.11.1. Standard Curve Construction 
To produce quantitative results of the target gene in the field samples a standard curve was 
created using external standards. The external standards were prepared with 10-fold serial 
dilutions of the recombinant DNA pGEM-T(1), with known concentrations. The Ct values 
were used to construct the standard curve with regards to the number of copies in each 
dilution, calculated from the initial concentration of plasmid DNA. Afterwards, it is possible to 
determine the number of viral particles in each sample extrapolating from the standard curve.   
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The recombinant DNA pGEM-T1(1) was diluted in 10-fold series; 5µL of the recombinant was 
pipetted into 45µL of RNase-free water, the mixture was vortexed and then 5µL was pipetted 
into a new tube with 45µL of RNase-free water. This procedure was repeated until 11 tubes 
were obtained with dilutions from 10-1 to 10-11. The dilution series (10-1 to 10-11) of the pGEM-
T1(1) were subjected to qPCR amplification to construct a standard curve. Each dilution was 
repeated in a series of 4 and the outlier was excluded from the analysis. 
These dilutions were subjected to qPCR with the same conditions referred previously in 
section 2.10- Materials and Methods. At the end the Ct value were registered. 
 
2.11.2. Specificity of the qPCR method 
In order to guarantee that the method only detects the targeted sequence (an 86bp fragment 
within the Polymerase gene of ChHV5), the specificity of the oligonucleotides (primers and 
probe) were checked by in silico analysis by performing searches against DNA sequences 
publicly available in databases (16th May 2019). This was quite relevant taking into 
consideration that the method was developed 17 years ago.  
Due to the lack of a set of ChHV5 negative turtle reference materials, the determination of 
the false positive rate (number of misclassified known negative samples divided by the total 
of known negative samples times 100) was not carried out. Instead, we used a set of 14 
herpesviruses positive samples from other taxa (Table 1) to demonstrate that the qPCR 
system was specific. The samples were subjected to qPCR with the same conditions referred 
previously. At the end the Ct value were registered. 
 
Table 1- Identification of the samples used to test the specificity of the qPCR. The subfamily 
and specie are referent to the virus.  
 
Sample identification Subfamily Specie Disease caused 
4505/09 
Avian 
Alphaherpesvirinae Gallid alphaherpesvirus 1 
Infectious 
larynhotracheitis 
4505/09  
Avian 
Alphaherpesvirinae Gallid alphaherpesvirus 2 Marek’s disease 
4788/88  
Avian 
Alphaherpesvirinae Psittacid herpesvirus 1 Pacheco’s disease 
2572-1 
Equine 
Alphaherpesvirinae Equid alphaherpesvirus 1 
Equine herpesvirus 
myeloencephalopathy 
44790 + 4814 Alphaherpesvirinae Felid alphaherpesvirus 1 Feline viral rhinotracheitis 
10520-17 Alphaherpesvirinae Canid alphaherpesvirus 1 Canine herpesvirus 
34878 Gammaherpesvirinae 
Alcelaphine 
gammaherpesvirus 1 
Bovine malignant 
catarrhal fever 
Porcine vaccines: 
Porcine gE, Suivax, 
PRV-WT, ADV- WT 
Alphaherpesvirinae Suid alphaherpesvirus 1 Aujeszky’s disease 
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2.11.3. Sensitivity the qPCR method (Limit of detection) 
The sensitivity of the qPCR method was expressed as the limit of detection (LOD) by using 
the serial dilutions of the pGEM-T1(1) recombinant DNA (10-1 to 10-11). The last dilution 
where all four replicates gave a positive and specific amplification was considered as the 
LOD. Again, the lack of a set of ChHV5 positive turtle reference material, hampered the 
determination of the false negative rate (number of misclassified known positive samples 
divided by the total of known positive samples times 100). These dilutions were subjected to 
qPCR with the same conditions referred previously. At the end the Ct value were registered. 
 
2.11.4. Reproducibility of the qPCR method 
The reproducibility of the method was tested by repeating the qPCR of the dilution series in 
three other independent runs. The qPCR amplification conditions and the reaction quantities 
were maintained, the variable was the CFX96™ Optical Reaction Modules (Bio-Rad). This 
measurement is to assess inter-assay variability. 
 
2.11.5.  Repeatability of the qPCR method 
The repeatability of the method was tested by repeating the dilution series from 10-2 until 10-6 
and subjecting this series to three independent runs qPCR amplifications using the same 
conditions with the CFX96™ Optical Reaction Module (Bio-Rad). This measurement is to 
assess intra-assay variability. 
 
2.12. Phylogenetic analysis of ChHV5 positive samples 
A subset of samples were subjected to conventional PCR with primers from the ChHV5 pol 
genes to be amplified and sequenced. For this purpose, the samples were selected based on 
the Ct value and the location where the animal was captured. The Ct value is inversely 
proportional to the herpesvirus DNA load therefore samples with the lowest Ct value were 
selected for the study.  
The genes chosen for analysis were: UL18, UL34, DNA polymerase and glycoprotein B.  
The primers selected amplify a partial sequence of UL18 for 1212bp. It encodes a major 
capsid protein gene of the virus. It shows similarities to the VP-23 gene “capsid triplex 
subunit 2” of the human herpesvirus 2. The UL34 gene is an 861bp long sequence that 
encodes a membrane-associated phosphoprotein. Two primers were used (UL34A and 
UL34B) that amplify two overlapping amplicons from the UL34 region. The primers used 
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amplify a final 483bp partial sequence within the DNA polymerase family B. It encodes a 
putative DNA polymerase catalytic subunit. Six pairs of primers were used for the 
glycoprotein B amplification that produce overlapping amplicons totalizing 2486bp. This 
membrane protein is predicted to be a signal peptide and to codify 3 transmembrane helices. 
These primers had previously been published and used for phylogenetic analysis and 
synthesized by STABVIDA (Caparica, Portugal) and its sequences are listed in Table 2 
(Patrício et al., 2012; Ene et al., 2005; Greenblatt et al., 2005; Quackenbush et al., 2001). A 
total of 5042bp were predicted to be obtained from each sample.   
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Table 2- Primers used for the amplification for the ChHV5 genes. 
 
 
Gene Reaction Primer sequence (5’-3’) 
Product 
length 
PCR 
amplification 
conditions 
Reference of 
the method 
DNA pol 
(GTHV) 
Forward 
(GTHV1) 
TGTCTGGAGGTGGCGGCCACG 
483bp 
94°C for 5 min, 
35 cycles of 
94°C for 30s, 
62°C for 30s, 
72°C for 30s, 
One cycle at 
72°C for 10 min 
(Quackenbush 
et al., 2001) Reverse 
(GTHV2) 
GACACGCAGGCCAAAAAGCGA 
UL18 
Forward AGGCCTGTATCTCCTGCTCA 
1212bp 
94ºC for 5 min, 
35 cycles of 
94ºC for 30s, 
58ºC for 45s, 
68ºC for 1 min, 
One cycle at 
68ºC for 5 min 
(Ene et al., 
2005) 
Reverse TATCGCGAGCTCGTACAATG 
UL34 
UL34-A 
Forward 
CCTGAGCAAATTTCTGGACCTG 
861bp 
94ºC for 5 min, 
35 cycles of 
94ºC for 30s, 
55ºC for 45s, 
68ºC for 30s, 
One cycle at 
68ºC for 5 min 
(R. J. 
Greenblatt et 
al., 2005) 
UL34-A 
Reverse 
AATTTTCGCGGCTTCTCG 
UL34-B 
Forward 
GGGCGGTTTTTGGGGGTCAG 
UL34-B 
Reverse 
ACTCAAGATCGCGGTCAGCAGA 
Glyco--
protein B 
(gB) 
gB-A 
Forward 
CCGTCCGGCAATGATGAAAAA 
2486bp 
94ºC for 5 min, 
35 cycles of 
94ºC for 30s, 
57ºC for 45s, 
68ºC for 30s, 
One cycle at 
68ºC for 5 min 
(R. J. 
Greenblatt et 
al., 2005) 
gB-A 
Reverse 
GTTGCAACTGCCGCCACTCCTG 
gB-B 
Forward 
TTCCGCTACCGCCATCAAACACAACT 
gB-B 
Reverse 
ATTAACCCCCGACGGCACCACAAGAG 
gB-C 
Forward 
TGCGCGTTATCCACTCTTCTTCCTAT 
gB-C 
Reverse 
TTTTTGGCCGCGACCCGTTTTC 
gB-D 
Forward 
GTCAACAACACGCGAGCCAGAGC 
gB-D 
Reverse 
AAACCCCGCCGAACATAAAATACTTG 
gB-E 
Forward 
CCTACTTGGGGTTGACGGAGAG 
gB-E 
Reverse 
GCCAGCGCCCCACCTACTAC 
gB-F 
Forward 
GCTGGCCGGCGTGCTCAAT 
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gB-F 
Reverse 
CTAGATACATACTGGCCGTGCTCGTC 
2.12.1. Conventional PCR conditions 
The stock solutions of the primers were diluted to a final concentration of 200pmol/µL, and 
the working solutions, at 50 pmol/µL, were prepared by dilution in dH2O. The PCR mixtures 
consisted of 6.5µL RNase free water, 12.5µL AccuStart II PCR SuperMix 2x, 0.5µL of each 
primer and 5µL of total DNA, totalling in 25µL of mixture.  
The amplified fragments resulting from each conventional PCR were analysed in an agarose 
gel electrophoresis. It enables the separation of the DNA fragments according to molecular 
size.  
The gel was prepared using TE Buffer (Tris-EDTA) and 1.5% agarose. To the mixture 
GreenSafe was added, a nucleic acid staining agent. When bound to DNA/RNA it emits a 
green fluorescence that be visualized when exposed to UV light. In the agarose gel, the 
marker QuickLoad (100bp) was run in parallel to the samples, allowing for the identification 
of the molecular size of each fragment. The products were run for approximately 40-60 
minutes at 120V. The results were visualized in a Chromato-Vue Transilluminator and the 
amplified DNA fragments size were compared with the bands from the 100bp marker. All the 
results were photo documented.  
 
2.12.2. Fragment purification from agarose gel 
DNA fragments were excised from the agarose gel using a razor blade and transferred into a 
microcentrifuge tube. Then, 3 volumes of Agarose Dissolving Buffer (ADB) solution was 
added to each tube and they were placed in a heated bath (55ºC) for 10 minutes until the 
agarose was completely melted. The solution was then transferred to a Zymo-Spin Column 
in a collection tube and centrifuged for 60 seconds. The flow-through was discarded. DNA 
wash buffer (200µL) was added to each tube and centrifuged for 30 seconds, with the flow-
through discarded at the end. This step was repeated to ensure the solution was properly 
washed. Finally, 15µL of DNA Elution Buffer was placed directly on the column matrix and 
placed in a 1.5mL tube. It was centrifuged for 60 seconds to elute the DNA. The resulting 
solution contained the purified DNA fragment of each PCR product. These samples were 
sent to STABVIDA (Caparica, Portugal) for Sanger sequencing.  
  
2.12.3. Phylogenetic analysis 
The nucleotide sequences from the UL18, UL34 and glycoprotein B from the 6 strains were 
subjected to a BLAST (Basic local alignment search tool) search 
(http://blast.ncbi.nlm.nih.gov/Blast.cgi) in the National Center for Biotechnology Information 
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(NCBI) data base (3rd June 2019). This search enabled to find other ChHV5 nucleotide 
sequences to which similarity was higher. From this search, accession numbers that showed 
a percentage of similarity over 80% were registered and the nucleotide sequences retrieved. 
The accession number of the sequences used as references for phylogenetic reconstruction 
are listed in Appendix 7.2. 
Nucleotide sequences of each gene were noted in FASTA format and aligned using the 
Clustal Omega algorithm (Sievers et al., 2011), implemented in MEGA version X (Kumar, 
Stecher, Li, Knyaz, & Tamura, 2018) with the following parameters for multiple alignments: 
gap opening penalty=3, gap extension penalty=1.8. The other parameters were kept as 
default and the files were exported in NEXUS format for further analysis. For each gene, the 
aligned sequences were corrected manually for optimal genetic similarity.  
For phylogenetic analysis MCMC inference methods were employed using BEAST v1.10.4 
(Suchard et al., 2018). The MCMC analyses were made using HKY (Hasegawa, Kishino, & 
Yano, 1985) and GTR (Tavaré, 1986) nucleotide substitution models. Each model ran under 
the assumptions of constant population size and exponential growth (Ho, Phillips, Cooper, & 
Drummond, 2005). The prior combinations were run for 100 million generations, subsampling 
every 10000 generations. The summary trees were created using TreeAnnotator v1.10.4 
(Suchard et al., 2018) and edited in FigTree v1.4.4 (Suchard et al., 2018). Phylogenies were 
constructed for each gene and for a concatenated gene matrix.  
 
2.13. Statistical analysis  
The association of size of the captured individuals (CCLn-n) and the Ct values of the skin 
samples within each location (Guinea-Bissau and Mauritania) was assessed using a Mann-
Whitney U test. The test was evaluated with a statistical significance of 5% (α=0.05).  
The ANOVA F-test was used to assess the statistical association between the turtle size, 
stage and the Ct value of the normal skin sample, the tumour score and Ct value and to test 
the similarities of the Ct values between locations. The test was evaluated with a statistical 
significance of 5% (α=0.05). Statistical association was established when p<0.05.  
The association between the presence of tumours and the size of turtles was evaluated 
using generalized additive modelling (GAM) available in package mcgv (Wood & Wood, 
2015). GAMs are semi-parametric models used to smooth functions to fit the data. It allows 
to create nonlinear relationships between the FP tumours and explanatory variables (in this 
case the size of turtles). Adult turtles were excluded from this analysis as they have a low 
risk of having tumours, and sample size was very reduced (n=5).  
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Figure 10- A work-flow diagram of the structure of Section 3- Results.  
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3. RESULTS (Figure 10) 
3.1. Characterization of the sample population 
The normal skin samples (i.e. FP-free samples) from Mauritania were coded in order of their 
capture, from M1 to M73. For animals with FP lesions, the code was FP and the number of 
the turtle from capture order, as above. Samples from Unhocomozinho were also coded from 
U1 to U36 and the FP biopsies respected the same rule as before.  
The captured green sea turtles were classified into three different life-stages based on their 
Curved Carapace Length (CCL): juvenile, sub-adult and adult. This classification follows 
previous studies with green sea turtles from the Atlantic region (Patrício et al. 2014), as there 
is no available report about the somatic growth of these aggregations. The CCL classes are: 
under 65cm they were classified as juveniles (Patrício et al., 2016), between 65cm and 83cm 
as sub-adults and over 83cm they were classified as adults, as this is the minimum size for 
nesting females from this population. Among the 109 captured individuals, morphometric 
information was taken of 108. Of these individuals 82 were juveniles (76%), 21 sub-adults 
(19.4%) and 5 adults (4.6%) and their distribution is shown in Figure 11. 
 
Figure 11- Distribution of the captured individuals in the CCL size classes with the 
respective number of individuals with macroscopic FP lesions. On the left a 
representation of the total sample population, on the right the distribution for Guinea-
Bissau (GB) and Mauritania (MAU). Created using Excel.  
The CCL of the captured green turtles ranged from 37.5 cm to 97cm (mean ± SD= 
59.09±11.67cm). The average CCL for individuals from Guinea-Bissau was 58.24cm 
(SD=15.3) and from Mauritania was 59.52cm (SD=9.44).  
The size of individuals affected with macroscopic FP lesions ranged between 39.7cm and 
92.5cm (mean ± SD= 56 ± 11.6125cm) while individuals without evidences of FP varied 
between 37.5cm and 97cm (mean ± SD= 60.22 ± 11.56cm). 
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The gender of the individuals was not determined given the evident absence of morphologic 
dimorphism before the adult life stage and the difficulty in examine the genitalia. The body 
mass was not registered for most the individuals due to lack of human resources and 
imbalanced working area (measures conducted onboard a small research vessel).  
 
3.1.1. Tumour scoring  
Each individual tumour was classified depending on the approximate diameter: Class A- less 
than 1cm; Class B- 1 to 4cm; Class C- greater than 4 to 10 cm; Class D- greater than 10cm. 
The turtles were then assigned an overall score, from 0 to 3, based on the number of lesions 
they had in each class (Table 3, Work & Balazs, 1999).  
 
Table 3- The tumour scoring criteria for placement of the individual in each category (Work & 
Balazs, 1999). 
 
Tumour class (tumour size in cm) Number of tumours present 
A (<1 cm) 0 1-5 >5 >5 
B (1- 4 cm) 0 1-5 >5 >5 
C (>4-10 cm) 0 0 1-3 >4 
D (>10 cm) 0 0 0 >1 
Tumour Score 0 1 2 3 
 
This scoring system reflects the spectrum of severity of FP lesions in green turtles. A score 
of 0 is attributed to non-afflicted turtles (Figure 12), 1 means lightly affected (Figure 13), 2 
moderately, and 3 are heavily afflicted individuals (Figure 14) (Balazs, 1991). 
The count of turtles in each tumour score category is presented in Table 4. The CCL of green 
turtles with tumour score 0 ranged from 37.5 to 97cm (mean ± SD = 60.22 ± 11.56cm), with 
score 1 from 42 to 92.5cm (mean ± SD = 55.12 ± 9.66cm) and with score 3 from 49.5 to 
87.5cm (mean ± SD = 65.5 ± 16.03cm). Only one turtle had a tumour score of 2 (CCL= 
39.7cm).  
 
 
 
 
 
Table 4- Count of turtles with each tumour score partitioned by life-stage. 
 
Life-stage 
Tumour score 
0 (n=76) 1 (n=27) 2 (n=1) 3 (n=4) 
Juvenile 53 26 1 2 
Sub-adult 20 0 0 1 
Adult 3 1 0 1 
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Figure 12- Image of a green sea turtle with FP tumour scoring 0 (original).  
 
Figure 13- Image of a green sea turtle with FP tumour scoring 1 (original).  
 
 
 
Figure 14- Image of a green sea turtle with FP tumour scoring 3 (original) 
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3.2. Analysis of the yield of total DNA extracted from tissue samples 
The DNA yield was determined for all the DNA preparations obtained from both normal and 
tumour skin samples. Skin samples were taken from 76 individuals, 76 normal skin samples 
and 28 tumour samples from FP afflicted individuals. In total 108 samples were obtained. For 
total DNA extraction, a 10% (10ng/100mL) homogenate (w/v) was prepared in PBS with 
each skin sample. DNA was extracted from 200µL of this suspension (0.2 mL- 0.02ng=20 
mg), which corresponds to the amount present in 20 mg of tissue and eluted in 100µL of 
PBS. Therefore, 1µL of the DNA preparation corresponds to the amount of nucleic acid 
extracted from approximately 0.2 mg of tissue. 
The DNA concentration varied between 6.9 and 51.7 ng/µL. For 21 turtles, normal and 
affected tissues were obtained. In these samples, the amount of DNA obtained from tumours 
was, in general, higher than from normal skin (mean ± SD= 38.11 ± 5.85 ng/mL and 18.34 ± 
19.48ng/mL, respectively). 
For the 108 samples, the mean value for normal skin was 17.44ng/mL, while for the tumour 
skin was 38.11ng/mL.  
 
3.3. Implementation and validation of the quantitative PCR method developed 
by Quackenbush et al., 2001  
ChHV5 has been implicated as the viral agent to cause the FP lesion observed in marine 
turtles through distinct laboratorial methods such as PCR assays (Devanter et al., 1996; 
Lackovich et al., 1999; Quackenbush et al., 1998), electron microscopy and transmission of 
filtered, cell-free homogenates to green sea turtles (Herbst et al., 1995; Herbst, Moretti, 
Brown, & Klein, 1995; Jacobson et al., 1991). Even though standard PCR methods show a 
strong correlation between the presence of the herpesvirus DNA polymerase gene and the 
FP tumours, it does not provide quantitative data of the herpesvirus DNA load present in the 
lesion and other tissue samples (Quackenbush et al., 2001). The method designed by 
Quackenbush et al. (2001) further implicates ChHV5 as the infectious agent by providing a 
way to quantify the viral DNA loads. The qPCR (Quackenbush et al., 2001) was implemented 
and validated through the construction in the laboratory before being used to infer the viral 
loads in the samples.  
 
3.3.1. Producing recombinant plasmid DNA pGEM-T1(1) 
To identify and characterize herpesviruses associated with the green turtle 
fibropapillomatosis, a consensus primer PCR which amplifies a region of herpesviral DNA 
polymerase gene was designed by VanDevanter et al. (1996), using degenerated primers in 
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a nested format. The first amplification uses the degenerated primers DFA (forward), ILK 
(forward), and KG1(reverse) allowing the amplification of an 800bp-long sequence within the 
coding region of DNA polymerase gene (Figure 15), containing highly conserved amino acids 
motifs of the DNA polymerase gene of the Alpha, Beta and Gammaherpesvirinae 
subfamilies. The subsequent semi-nested PCR uses the degenerate primer (DFA) and a 
green turtle specific herpesvirus 2 primer (GTHV2) designed after the turtle herpesvirus DNA 
polymerase gene was entirely sequenced and made public. Primers DFA and GTHV2 
amplify a sequence of 483bp of herpesvirus DNA polymerase (Figure 15). This fragment 
contains discriminatory power for phylogenetic analysis which shall be discussed further 
ahead.  
 
Figure 15- Relative location of the primers used in Herpesvirus nested PCR (Devanter et 
al., 1996; Quackenbush et al., 2001).  
 
Using the system described above, a 483bp fragment was obtained from a green sea turtle, 
and cloned into the pGEM T Vector generating the recombinant plasmid pGEM-T1(1). A 
sample of this recombinant was provided at the beginning of this work for this thesis. 
In order to obtain pGEM-T1(T1) DNA in enough amount for the validation of the method, 
E.coli DH5-α cells were transformed and DNA was extracted as described in Section 2.4.-
2.6.- Materials and Methods.  
 
3.3.2. Quantification and purity evaluation of pGEM-T1(1)  
Plasmid DNA yield was assessed by absorbance at 260 nm and the purity regarding sugar 
and protein contaminants was determined by investigating the optical density at 230 and 280 
nm. The results are presented in the following table (Table 5). 
 
Table 5- Nucleic acid quantification of the plasmid DNA colony T1(1).  
Colony identification Nucleic acid quantification (ng/µL) 260/280 ratio 260/230 ratio 
T1(1) 338.3 1.90 2.06 
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3.3.3. Analysis of recombinant DNA by restriction enzyme hydrolysis 
The restriction enzymes cleave the specific sites in the circular plasmid, creating two linear 
DNA fragments that can be visualized in agarose gel after electrophoresis. Fragments are 
visualized under UV light (Chromato-Vue Transilluminator) by staining the gel with molecules 
that intercalate dsDNA.  
In this case, the hydrolysis products comprise the pGEM vector (3015bp) and the inserted, 
around 483bp-long (Figure 16). The predicted bands were confirmed in a 1.5% agarose gel 
in TBE buffer, stained with Red-Safe™ DNA stain (Applied Biological Material Inc.).  
 
Figure 16- Photograph of the agarose gel with the resulting restriction fragments of the 
pGEM-T1(1) with Sac I and Spe II enzymes. Line M- DNA markers, lines 1 to 6 
correspond to different clones that resulted from the transformation.  
 
 
The insert fragment from clone 1, was then cut from the agarose gel and subjected to 
purification using a commercial kit as described before. The product was Sanger sequenced 
to confirm the presence of the desired insert. Sequencing of polymerase gene fragment was 
carried out during this work as described in Section 2.9. The sequence was subjected to a 
BLAST (Basic local alignment search tool) search (http://blast.ncbi.nlm.nih.gov/Blast.cgi) in 
the National Center for Biotechnology Information (NCBI) data base (28th May 2019) to 
confirm its identity (Figure 17). 
 
M         1        2        3        4        5         6 
Insert 
Linearized pGEM 
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Figure 17- Results from BLAST search (28th May 2019) of the pGEM-T1(1) sequence. 
The sequences are aligned with the pGEM sequence on top and the sequence 
AF035003.3 on bottom. (https://blast.ncbi.nlm.nih.gov/Blast.cgi).  
 
 
3.3.4. pGEM-T1(1) sequence analysis 
The sequence showed a similarity of 99% with a sequence AF035003.3 (sequence from a 
green turtle with 504bp). The sequence identity matches in 497 of the 503 nucleotides with 0 
gaps. The variable sites are at position 49 Y, 196 M, 290 W, 487 R, 493 R, 496 K, and 502 R 
of the AF035003.3 sequence. The differences in the sequences are highlighted in the Figure 
18.  
 
Figure 18- The aligned sequences pGEM-T1(1) (top sequence) and AF035003.3 (bottom 
sequence) using Jalview Version 2 (Waterhouse, Procter, Martin, Clamp, & Barton, 
2009). 
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3.3.5. Standard curve construction  
The standard curve was generated by the CFX Manager™ Software using the dilutions up to 
10-8 shown in Figure 19 (Bio-Rad, USA). 
The concentration of pGEM-T(1) DNA sample was 338.3ng/mL. From this value the number 
of copies in each dilution was calculated the following formula: 
DNA copy number in 5µL PCR mixture= amount of DNA in the reaction (g)/[molecular weight 
of DNA/ 6.022x1023] 
The result was 4.69x1011 copies of herpesvirus in each 5µL of DNA, the amount used in each 
PCR. The number of copies in each dilution was extrapolated from the original sample.  
The optimal slope for a standard curve is -3.32 with a correlation coefficient (R2) close to 1. 
Removing obvious outlier helps create an optimal standard curve (Singh & Roy-Chowdhuri, 
2016). The resulting standard curve is shown in figure 20. The slope revealed 100% 
amplification efficiency (slope= 3.322) and a high correlation coefficient (R2=0.995). The 
equation for the linear regression line (y=mx+b) is y= -3.322x + 44.11 and shown in Figure 
21. 
 
Figure 19- The relative fluorescence units (RFU) on the y-axis and threshold cycle (Ct) 
on the x-axis of the dilution series from 10-1 to 10-8 (Image from Bio-Rad CFX 
Manager™). 
 
 
47 
 
Figure 20- Standard curve constructed by Bio-Rad CFX Manager™ showing the Cq 
value on the y-axis (Cq- threshold cycle (Ct)) plotted against the log of the pGEM-
T1(1) dilutions on the x-axis. (Image from Bio-Rad CFX Manager™).  
 
 
Figure 21- Standard curve obtained by linear regression analysis of the dilution samples 
with Ct values on the y axis and the number of copies on the x axis using Excel. 
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3.3.6. Specificity of the qPCR 
The results of the PCR amplification of herpesvirus positive samples from individuals of other 
taxa are shown in Figure 22. None of the samples used to test the specificity of qPCR 
crossed the threshold line, demonstrating that the method does not amplify other herpesvirus 
positive samples besides ChHV5. The positive control (dilution 10-3 of pGEM-T1(1)) 
registered a Ct value of 13.13.  
 
Figure 22- The relative fluorescence units (RFU) and threshold cycle (Ct) of the 
herpesvirus positive samples. + is the positive control (Image from Bio-Rad CFX 
Manager™). 
 
3.3.7. Sensitivity of the qPCR method (Limit of detection) 
The limit of detection (LOD) is the lowest amount of DNA in a sample that can be detected 
with stated probability even though it may not be quantified as an exact value. LOD is the 
concentration that produces at least 95% positive replicates.  
The resulting Ct of the dilution series revealed to be positive until the dilution 10-11.. From this 
we can estipulate that the LOD of qPCR method is 5 copies of viral DNA (1.8x10-17g) 
deducted from the standard curve. 
 
3.3.8. Repeatability of the qPCR method 
The results of the PCR amplification of the dilution series using other CFX96™ Optical 
Reaction Module (Bio-Rad) machine number 360 are shown in Table 6. The standard 
deviation (SD) and coefficient of variation (CV %) were calculated for within each 
amplification replicate.  
+ 
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Table 6- Intra-assay variability of the qPCR method with the respective SD and CV % values. 
 
Dilution Mean Ct SD CV (%) 
10
-1
 3.24 0.368 11 
10
-2
 6.97 0.742 10.6 
10
-3
 11.31 0.328 2.89 
10
-4
 15.13 0.082 0.54 
10
-5
 17.37 0.3 1.72 
10
-6
 21.03 0.258 1.23 
10
-7
 24.07 0.188 0.77 
10
-8
 26.94 0.331 1.22 
10
-9
 30.18 0.38 1.26 
10
-10
 35.35 0.59 1.67 
10
-11
 37.87 0.89 2.35 
 
3.3.9. Reproducibility of the qPCR method 
The results of the PCR amplification of a new dilution series (10-2 to 10-6) using different 
CFX96™ Optical Reaction Module (Bio-Rad) machines are shown in Table 7. The standard 
deviation and the coefficient of variation were calculated for within and between the dilution 
series.  
 
Table 7- Intra-assay and inter-assay variability of the qPCR method with the respective SD 
and CV % values. 
 
Dilution Machine Mean SD CV (%) 
10
-2
 
173 8.78 
8.01 
0.169 
0.692 
1.9 
8.6 174 7.16 0.109 1.5 
360 8.15 0.189 2.4 
10
-3
 173 13.03 12.17 0.075 
0.731 
0.58 
6.0  174 12.09  0.175 1.44 
 360 11.38  0.315 2.77 
10
-4
 
173 15.84 
15.51 
0.089 
0.304 
0.56 
1.96 174 15.49 0.203 1.31 
360 15.21 0.15 0.99 
10
-5
 173 18.73 18.85 0.190 
0.43 
1.0 
2.28  174 18.62  0.439 2.36 
 360 19.20  0.442 2.3 
10
-6
 
173 22.05 
21.59 
0.133 
0.394 
0.6 
1.82 174 21.30 0.304 1.42 
360 21.42 0.182 0.8 
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3.4. Screening of green turtle skin samples by qPCR 
 DNA extracted from skin samples was screened by qPCR, allowing to identify which turtles 
were positive to ChHV5 and also providing quantitative information regarding the viral loads 
present in the affected tissues. Recombinant DNA pGEM-T1(1) was used as a positive 
control in all amplification reactions. In Table 8 are the primers used for the qPCR reactions.  
 
Table 8- Primers and probe used in the qPCR reaction. Note- Tartaruga RT reverse is a 
reverse complement sequence. 
 
 
The cut-off for the Ct was 38. For the 28 tumor samples, 24 were positive in the qPCR, 
confirming the strong correlation between FP and ChHV5 presence. The Ct values 
determined in the tissue samples ranged from 21.10 to 35.38 in tumor biopsies with a mean 
of 27.22 (Figure 23). Appendix 7.1. contains the Ct value of each sample. The blank spaces 
represent negative reactions/lack of amplification or non-amplified samples.  
The results of the qPCR of the samples showed that 26 (68.4%) of the normal skin samples 
from Mauritania were positive for ChHV5-DNA, while for Guinea-Bissau the value was 
smaller, namely 5 (approximately 14%) (Figure 24). The mean Ct of normal skin sample was 
35.24, however most ‘healthy’ skin samples did not yield a Ct value (negative for ChHV5 
DNA). 
The viral DNA copy number for each sample was calculated using the following equation: 
Quantity=10(
  - 
 
 ), where b is the y-int=44.11 and m is the slope=-3.322. The results are 
shown in Appendix 7.1.  
The tumour samples presented lower Ct values than the normal skin samples as shown in 
Figures 23 and 24. 
 
 
 
 
 
Identification Sequence (5’-3’) 
Product 
length 
Position in genome 
Accession number: 
AF299107.1 
Tartaruga RT Forward 
Tartaruga RT Reverse 
Tartaruga probe 
ACTGGCTGGCACTCAGGAAA 
CAGCTGCTGCTTGTCCAAAA 
[6FAM] -CGATGAAAAC-CGCACCGAGCGA- [TAMRA] 
86bp 
169- 189 
236-255 
203-224 
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Figure 23- The relative fluorescence units (RFU) on the y-axis and threshold cycle (Ct) 
on the x-axis of each tumour sample (red lines) and the positive controls 10-2 and 10-3 
(blue lines) (Image from Bio-Rad CFX Manager™). 
 
 
 
 
Figure 24- The relative fluorescence units (RFU) on the y-axis and threshold cycle (Ct) 
on the x-axis of each normal skin sample (green lines) and the positive controls 10-2 
and 10-3 (blue lines) (Image from Bio-Rad CFX Manager™). 
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3.5. Phylogenetic analysis of the ChHV5 positive samples  
3.5.1. Amplification of ChHV5 pol genes from ChHV5 positive samples 
The samples selected for the phylogenetical analysis were U11FP2, U18FP, U24FP, M1FP, 
M4FP and M18FP. The characteristics of the samples regarding the specimens, are 
described in Table 9.  
 
Table 9- Identification of the sample subgroup for PCR amplification of the ChHV5 pol genes 
Turtle_ID 
Sample 
Number 
Date of 
capture 
Place of capture 
CCL 
(cm) 
CCW 
(cm) 
Tail 
length 
(cm) 
Weight 
(kg) 
Ct 
value 
11_GB U11FP2 22/03/2018 
Etimbato, 
Unhocomo 
87,5 87,0 
Not 
measured 
Not 
Measured 
21.20 
18_GB U18FP 21/10/2018 
Ancante, 
Unhocomozinho 
50 44 2.5 12.0 26.63 
24_GB U24FP 25/10/2018 
Etimbato, 
Unhocomo 
50 45.0 2.5 12,0 28.58 
1_TID_18 M1FP 08/05/2018 Tidra 61 
Not 
Measured 
Not 
Measured 
Not 
Measured 
22.68 
4_TID_18 M4FP 08/05/2018 Tidra 42 
Not 
Measured 
Not 
Measured 
Not 
Measured 
20.26 
18_TID_18 M18FP 08/05/2018 Tidra 49.4 
Not 
measured 
Not 
Measured 
Not 
Measured 
21.63 
 
The PCR method described by Quackenbush (2001) and the PCR conditions for each gene 
were detailed in the Materials and Methods Section 2.12.1. In Table 2, the primers used and 
the amplification conditions are described for each gene. In total, 5042bp were expected to 
be obtained from each sample.  
The amplification of the complete glycoprotein B gene was attempted by six overlapping 
fragments (A to F). However only fragment F was successfully sequenced in the 6 strains. 
The UL34 region was amplified with two overlapping fragments. For the remaining regions 
(DNA polymerase and UL18), only one fragment was amplified. A total of 55 fragments were 
successfully amplified from the sub-group, meaning that 5 fragments were not obtained due 
to insufficient or absent amplification. The fragments were given codes according to the 
sample number and the gene amplified (example U3-UL18, U11-UL18, etc.). Figures 25-27 
represent some of the DNA fragments obtained from the various PCR amplifications. The 
amplicons were purified as described in Materials and Methods section 2.12.2. and were 
sent to STABVIDA (Caparica, Portugal) for Sanger sequencing. 
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Figure 25- Visualization of the agarose gel using Chromato-Vue Transilluminator. Line 
M- DNA markers, the following pair of lines correspond to amplified glycoprotein 
fragments from A to F of the sample M4. The arrow head points to a ~500bp DNA 
fragment.  
 
 
Figure 26- Visualization of the agarose gel using Chromato-Vue Transilluminator. Line 
M- DNA markers. The top arrow head points to a ~1200bp fragment and the bottom 
arrow head to a ~500 DNA fragment.  
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Figure 27- Visualization of the agarose gel using Chromato-Vue Transilluminator. Line 
M- DNA markers. The arrow head points to a ~500bp DNA fragment.  
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3.5.2. Sequencing analysis (Sanger method) and nucleotide comparison  
Of the 55 samples sent to STABVIDA, only 32 were successfully sequenced. Given the lack 
of quality reads, the DNA pol partial gene was not considered for the phylogenetic analysis. 
An additional ORF (HP20) was identified within the fragment amplified for the UL18 gene.  
Nucleotide sequences were used rather than protein sequences to evaluate populations 
geographically separated within the same species to explore variability.  
 
3.5.3. Phylogenetic reconstruction 
As not all partial genes sequences were obtained from the ChHV5 positive samples the 
number of sequences used for each gene tree varied. The sequences available in GenBank 
for each sample are also not available for all partial genes thus the number of geographic 
sites also varied. 
For the glycoprotein B gene, three sequences were used from Guinea-Bissau, three from 
Mauritania and 20 reference sequences from California, Costa Rica, Florida, Barbados, 
Australia, Puerto Rico, Sao Tome e Principe and Hawaii. The statistical model used was the 
HKY model (Hasegawa et al., 1985).  
For the UL18 and HP20 gene, two sequences were used from Guinea-Bissau, three from 
Mauritania and 11 reference sequences from Florida, Puerto Rico and Hawaii. The statistical 
model used was the GTR model (Tavaré, 1986).  
Regarding the UL34 gene, one sequence was used from Guinea-Bissau, two from 
Mauritania and 16 reference sequences from California, Costa Rica, Florida, Barbados, 
Australia, Puerto Rico, Sao Tome e Principe and Hawaii. The statistical model used was the 
GTR model (Tavaré, 1986).  
For the concatemers, two sequences were used from Guinea-Bissau, three from Mauritania 
and 22 reference sequences from Puerto Rico, São Tomé e Principe, Hawaii, Australia, 
Florida, Barbados, Costa Rica and California. The statistical model used was the HKY model 
(Hasegawa et al., 1985).  
The codon positions 1st, 2nd, 3rd and non-coding were all included. All the trees were drawn to 
scale with branch lengths in the same units as those of the evolutionary distances used to 
infer the phylogenetic tree. The bootstrap method was employed with 1000 replicates.  
However, only the UL34 gene-based tree is presented for discussion for the other trees did 
not compute correctly according to what is known in the literature.  
 
3.5.4. Phylogeographical analysis of the ChHV5  
The gene and concatemered trees are unrooted meaning the likelihood of the leave 
(operational taxonomical units) are calculated without a known ancestor.  
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The UL34 gene-based tree formed four distinct clusters, supported by a bootstrap value of 
>98%, each two sharing a common ancestor (Figure 28). The scale represents the time 
distance of the samples.  
Figure 28 shows the 4 geographical groups that formed in the UL34 gene tree and figure 29 
shows a time-tree for the samples used. 
Figure 29 shows a time-tree with a scale of the time in which the samples were taken. 
In figure 30 represents the HP20 gene tree and figure 31 the concatemered tree.  All the 
trees were constructed using the methodology described in 2.12.3- Materials and Methods 
and in 3.5.3.-Results. 
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Figure 28- Phylogenetic tree based on gene UL34 inferred using BEAST V1.10.4, edited using FigTree V1.4.4., with visual colour-coded 
representation of each sequence on a global map and the corresponding geographically groups. The corresponding bootstrap value 
next to each nodes (original). 
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Figure 29- Phylogenetic tree based on gene UL34 inferred using BEAST V1.10.4, edited using FigTree V1.4.4., with visual colour-coded 
representation of each sequence on a global map and a colour-coded time bar of each samples (original). 
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Figure 30- Phylogenetic tree based on gene HP20 inferred using BEAST V1.10.4, edited using FigTree V1.4.4., with visual colour-coded 
representation of each sequence on a global map and the corresponding geographically groups (original). 
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Figure 31- Phylogenetic tree of the concatermered genes inferred using BEAST V1.10.4, edited using FigTree V1.4.4., with visual colour-
coded representation of each sequence on a global map and the corresponding geographically groups (original). 
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3.6. Statistical analysis results 
All the information gathered regarding the captured turtles in available in appendix 7.1.  
The size of the turtles (CCL) and the resulting Ct values were tested for normality using the 
Shapiro-Wilk test. The CCL was not normally distributed (W = 0.938, p-value = 7.86 x 10-05) 
and the Ct values were marginally normally distributed (W = 0.940. p-value = 0.03). Thus, for 
consistency, non-parametric tests were employed for statistical analysis. 
No significant difference was found on the CCL of turtles between the two study sites (W = 
1101, p-value = 0.2049). There was also no significant difference on Ct values of the normal 
skin samples or the turtle life-stage (p-value=0.68322) between sites.  Marginal significance 
was found between the presence of tumours and the size of the turtle (p-value = 0.0576). 
The average size of the turtles with FP lesions was less than that of animals without FP as 
shown in Figure 32. 
No statistical association was found between the Ct obtained for the tumour samples and the 
geographic locations (p>0.05), however the normal skin samples were significantly different 
(p-value = 0.00231<0.005) between locations. The Ct values were higher in turtles from 
Guinea-Bissau (GB), as shown in figure 32, meaning the samples from Mauritania (MAU) 
had higher viral loads (as Ct is inversely correlated with viral load).  
The minimal adequate GAM showed that the CCL is significantly correlated with FP risk 
(GAM edf= 2.846, ref.df= 3.572, = 9.499, p<0.05).  The function was non-monotonic (figure 
32), as the FP lesions increase with the CCL, plateauing around 50-55cm and then 
decreasing (Figure 33).  
 
Figure 32- Boxplot showing CCL range (cm) of individual with (YES) and without (NO) 
FP lesions on the left and on the right showing the mean Ct value of normal skin 
(Ct_N) from Guinea-Bissau (GB) and Mauritania (MAU). Made using RStudio 
(RStudioTeam, 2018).  
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Figure 33- Graphical summary of GAM fitted to the CCL and FP lesions data. Made 
using RStudio (RStudioTeam, 2018).  
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4. DISCUSSION 
Prevalence of Fibropapillomatosis and expression 
Fibropapillomatosis, a panzootic neoplastic disease, was first documented in the 1940s’ 
(Smith and Coates, 1938). However, little information is available about this disease in sea 
turtles of West Africa (Duarte et al., 2012; Formia et al., 2007). This study is the first 
virological report of ChHV5, the leading aetiological agent candidate for FP, in green sea 
turtles from Guinea-Bissau (GB) and Mauritania (MAU).  
The total prevalence of individuals with FP tumours was 32 of the 108 analysed (27%), with 
12 (33%) in GB and 20 (28%) in MAU. Given this is the first report of FP in the region, the 
prevalence cannot be compared to data from previous studies on the same geographic sites. 
However, compared to other regions worldwide with reports of FP, this prevalence is lower 
than average, i.e. Hawaiian Islands up to 92% (Balazs, 1991); Florida up to 72.5% 
(Lackovich et al., 1999); Gulf of Mexico: 51.9% (Foley, Schroeder, Redlow, Fick-Child, & 
Teas, 2005); Indian River Lagoon, Florida: 61.6% (Hirama & Ehrhart, 2007); Australia up to 
70% (Aguirre et al., 1999); Puerto Manglar: up to 75% (Patrício et al., 2016).  
High prevalence of FP have been linked to anthropogenic activity and degradation of habitat 
(Keller et al., 2014; Van Houtan et al., 2010; Williams et al., 1994), and as the detection of 
ChHV5 variants have been shown to pre-date major outbreaks of the disease (Herbst et al., 
2004; Patrício et al., 2012), this further implicates the role the environment has in influencing 
the expression of the disease. The sites where the turtles were captured for this study have 
very little human activity, limited to artisanal fisheries and some few local inhabitants. This 
may explain the lower prevalence registered in these areas.  Another important factor is the 
high fidelity to foraging sites that green turtles typically demonstrate (Hirama & Ehrhart, 2007; 
Patricio et al., 2011). This behaviour may be important in limiting the spread of the infection 
from other regions with high FP prevalence (Patrício et al., 2016; Work et al., 2015).  
Captured turtles with FP lesions were marginally smaller (mean=56.00cm) than those without 
(mean=60.22cm).  Even though these results are inconsistent with previous studies (Aguirre, 
Balazs, Zimmerman, & Spraker, 1994; Baptistotte, 2007; Foley et al., 2005) the average size 
of the afflicted turtles is in accordance to most studies (Balazs, 1991; Dos Santos et al., 
2010; Foley et al., 2005; Patrício et al., 2016). Our study showed that turtles with FP ranged 
from 39.7 to 97cm. The lower risk of lesions in smaller size classes (≤38cm) along with the 
high prevalence in intermediate juvenile size classes, as shown in Figure 33, supports the 
hypothesis that the FP associated agent is acquired after the recruitment of juveniles to the 
neritic zone, meaning local infection (Ene et al., 2005; Herbst, 1994; Rodenbusch et al., 
2014).  The average recruitment size is 30cm. Patrício et al. (2016), demonstrated that it 
takes up to 3 years for FP expression after recruitment, and up to 4 years for full recovery 
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after the disease expression. Assuming a somatic growth of 5cm per year  (Patrício, Diez, & 
van Dam, 2014), this supports the peak of FP risk around 45-55cm, as observed here.  
In our study, the predominant FP tumour score was 1. The average size of the turtles 
increased in higher tumour scores. This phenomenon has been observed in other turtle 
populations (Work, Balazs, Rameyer, & Morris, 2004; Work, Balazs, Wolcott, & Morris, 2003) 
and is consistent with the development of tumours over time.  
Although in most studies larger size classes are rarely afflicted (>80cm), which could 
potentially be explained due to increasing resistance to disease with age (Foley et al., 2005; 
Hirama & Ehrhart, 2007; Patrício et al., 2016; Work et al., 2004), in our study of the five 
adults captured, two had FP. One of the individuals had a tumour score of 1 and the other 
was heavily afflicted (tumour score=3). Despite tumour regression having been documented 
(Patrício et al., 2016; Tagliolatto, Guimarães, Lobo-Hajdu, & Monteiro-Neto, 2016), the 
pathway is still unclear. The adult (ID 19_GB) with tumour score 1 may potentially be going 
through tumour regression, which could explain the non-detection of virus in the tumour 
sampled. The continuation of the in-water capture-mark-recapture monitoring of the green 
turtles in GB may confirm this hypothesis, if this individual is recaptured in the future. The 
development of FP has also been linked to other co-infections and/or the immunological 
status of the individuals, which may explain why some animals develop more severe 
infections than others (Herbst & Klein, 1995). The heavily afflicted individual may have been 
exposed to other factors that led to development of the disease. A limiting factor to the 
assessment of the individuals in this study may have been the inability to collect information 
regarding their overall health condition through haematological parameters, which may be 
linked to the development of the disease. 
It is to acknowledge that the sample size, particularly for GB, was small and may not 
represent the full scale of ChHV5 infectivity prevalence. The projects in GB and MAU are 
ongoing so further research shall give more insight into the prevalence of ChHV5 in these 
sea populations.  
 
ChHV5 prevalence 
A total of 55 of the 108 samples (51%) screened by qPCR were positive, 31 of the 76 normal 
skin samples (40%) and 24 of the 28 tumour samples (86%). Overall, 42 of the 76 (55%) 
individuals tested were positive to the detection of ChHV5.  
The detection of ChHV5 in most (86%) of the tumour samples is consistent with the role of 
this virus as aetiological agent of FP (Yuanan Lu et al., 2000; Quackenbush et al., 1998). 
The high positive percentage also demonstrates that tumour samples are the best matrix for 
viral detection. However, this study also revealed a proportion of asymptomatic individuals 
(21 turtles) that tested positive for ChHV5.  
This phenomenon was higher in turtles captured from MAU (32% of clinical healthy 
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individuals) than those from GB (16%). The Ct values of the normal skin samples were also 
significantly lower in the turtles from MAU, indicating higher viral loads in the tissues. Given 
that FP is likely a multi-factorial disease, this difference could indicate a difference in 
resistance in the populations or environment factors that, in combination with herd immunity, 
may influence the prevalence/ development of FP in each region (Alfaro-Núñez et al., 2014; 
Patrício et al., 2016; Work et al., 2001). Given that the populations from these areas are 
small, the influence of a spreader may be particularly important in these locations (Patrício et 
al., 2016). Even though the FP prevalence was low, the high viral loads in the MAU 
population and the high prevalence of ChHV5 DNA may mean that there could be a start of 
an epidemic linked to an individual with very high viral shedding. Vigilance of the evolution of 
this group is important as the results suggest a high FP risk.  
Our qPCR results suggest that these turtles may be carriers of the virus (asymptomatic 
reservoirs), or alternatively, may undergo early infection or latent infection, meaning that they 
may develop clinical disease in the future (Alfaro-Núñez et al., 2014; Quackenbush et al., 
2001). Even though this result does not correlate to the prevalence of FP, it is important 
evidence to help understand the pathogenesis of the disease and supports its  panzootic 
status (Herbst & Klein, 1995; Herbst, 1994). 
Only 36% of the samples from non-tumoured areas of FP exhibiting turtles were positive to 
ChHV5. This result is in concordance with the detection of ChHV5 found by some studies 
(Chaves et al., 2017; Quackenbush et al., 2001), however is lower than the value obtained in 
others reports from other regions (Chaves et al., 2017; Yuanan Lu et al., 2000; Page-Karjian 
et al., 2012). Latency, a known ability within herpesviruses, is an important point to research 
with ChHV5. This virus is not a “new” virus, as research has shown that it has co-evolved 
with its’ host for at least 8.9 millions of years (Herbst et al., 2004; Patrício et al., 2012). They 
have the ability, after establishing latency, to have minimal viral expression to avoid detection 
by the immune system. This may lead to an unequal tissue distribution within the same 
individual, were only the affected tissue has high viral loads. During the active viraemic 
phase, viral DNA may be detected throughout the body, while in chronic infections viral 
activity may be limited to tumours (Alfaro-Núñez et al., 2014), which may explain this 
difference in detection between sample type and between studies.   
There was no statistical significance between the tumour score and the Ct value in tumour 
samples. This reveals that the viral load is unrelated to the severity of the tumours. 
Lastly, the ChHV5 DNA copies were substantially higher in tumour samples (range= 
4.23E+02 to 1.15E+07 copies) compared to samples of normal skin tissue (range=6.95E+01 
to 4.67E+03 copies), further implicating the ChHV5 in the formation of FP tumours.  
 
Validation of the method for ChHV5 detection by Quackenbush et al. (2001) 
The standard curve showed a 100% efficiency (equation= [10(-1/slope-1)]) demonstrating the 
66 
 
robustness of the qPCR method. This result, along with the results of the specificity of this 
method, demonstrate that the primers designed by Quackenbush (2001) are efficient and 
precise in the amplification of the target region, even though they were only tested for cross-
reactivity by in silico analysis. This method also revealed a low LOD reflecting its high 
sensitivity.  
In regard to the reproducibility and repeatability of the qPCR assay, results showed some 
variability. In the intra-assay test the dilutions 10-1 and 10-2 showed higher variation 
percentages (10.6%-11%) however the other dilutions revealed low variations (0.54%-
2.89%). In the inter-assay tests the dilutions 10-2 and 10-3 showed higher inter-assay 
variation (6%-8.6%), despite the other dilutions revealed low variations (1.82%-2.28%). 
These results indicate that the qPCR assay has more reliable results with lower DNA copies 
than with high, as expected. However, this method still reveals high repeatability and 
reproducibility as all CV values were <20% (Page-Karjian et al., 2015).  
qPCR has the advantage of being a fast and quantitative method for detection of this virus. 
However, other methods have been described for the detection of ChHV5 in both tumour and 
non-tumour samples, namely PCR assay. Alfaro-Núñez et al. (2014) described a sensitive 
singleplex assay that revealed to have better amplification levels that the standard nested 
assay described by Quackenbush et al. (2001) used in this study. This competitive 
alternative could be considered for future research. The limitation of the singleplex assay 
method is that does not give quantitative information of the viral load.  
This quantitative feature of qPCR allows to furthermore implicate the virus as causative 
agent of FP, for not only does it reveal whether a sample is positive or not, but it also allows 
to estimate the viral load present.   
 
ChHV5 phylogenetic analysis 
Previous phylogenetic analysis of ChHV5 variants showed that there is a strong spatial 
heterogeneity in the distributions of variants (Greenblatt et al., 2005; Herbst et al., 2004; 
Patrício et al., 2012). Patrício et al. (2012) identified four major geographical groups that 
included: the eastern Pacific group (samples from San Diego and Costa Rica); the western 
Atlantic/eastern Caribbean group (samples from Florida and Barbados); the Atlantic group 
(samples from São Tomé e Principe and Puerto Rico); the mid-west Pacific group (samples 
from Australia and Hawaii).  
From phylogenetic analysis based on the UL34 sequences obtained from GB and MAU and 
16 available sequences from the NCBI database, the West African sequences clustered with 
the Atlantic group (Figure 26), along with the samples from Puerto Rico and São Tomé e 
Principe. This result is as expected, given the geographical location of the new sequences. In 
our tree, the other samples also clustered as previous studies have shown (Patrício et al., 
2012). The HP20 gene formed two clusters (Atlantic group and Western Atlantic/Eastern 
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Caribbean group) however the Western Atlantic group did not form a single clade as in 
previous literature (Patrício et al., 2012). This may due to the different species used in the 
analysis (Caretta caretta, Lepidochelys olivacea and Lepidochelys kempii) and the small 
sample group. The concatemered tree also showed some inconsistencies as the Western 
Atlantic group also did not cluster together and the sample U18 from GB formed its own 
node.  
Sea turtles have a complex life history, passing through an oceanic stage (the “lost years”), 
then as juveniles recruiting to a foraging area where they remain for several years (Patrício 
et al., 2012). These foraging areas are often cohabited by juveniles from different nesting 
areas. Evidence shows that infection normally occurs during this phase highlighting the 
importance of studying this life-stage of the turtles (Ene et al., 2005). Given that the 
individuals are most likely infected in the neritic areas, then the similarities between ChHV5 
variants within each geographical group are consistent with horizontal transmission. The 
clear geographical isolations and divergence of the virus also supports this (Patrício et al., 
2012). It also demonstrates that the viral particles are probably transmitted and distributed 
through skin shedding (Patrício et al., 2012; Work et al., 2017).  
The closeness of the Puerto Rican and African variants is unexpected, however Patrício et 
al. (2012) suggested that the equatorial current that exists between the Gulf of Guinea and 
Brazil (with a northern arm continuing to the Eastern Greater Antilles) may be responsible of 
the dispersal of hatchlings from Puerto Rico to eastern Atlantic waters. Moreover,  mixed-
stock analysis of the mitochondrial DNA demonstrated that shared haplotypes between the 
Puerto Rican foraging areas and West African rookeries (Patrício et al., 2012), indicated a 
possible viral gene flow between the areas.  
Phylogenetic analysis is also important in understanding the co-evolution between the host 
and virus. The identification of viral variants may explain differences in pathogenesis (Alfaro-
Núñez et al., 2014), one of the lacunas that needs investigation in this disease. Host specific 
response to infectious diseases is likely heritable and may explain the differences observed 
in the individuals, however there is a possibility that the genetic variant may also be 
responsible for disease susceptibility and pathogenicity (Alfaro-Núñez et al., 2014). ChHV5 
has co-evolved with its turtles’ hosts for at least 8.9 millions of years (Patrício et al., 2012). 
Recently, it has been proposed that disrupted co-evolution between the host and virus may 
explain the variations in disease outcomes, however it has not been proven adequate in 
explaining the heterogeneity of FP pathology (Alfaro-Núñez et al., 2014). This leads back to 
other factors being more likely cause of FP expression, such as environmental factors and 
herd immunity.  
The other trees (based on genes UL18, glycoprotein B and HP20) and the concatemered 
tree revealed contradicting information in comparison of what is presently accepted, 
therefore were not presented in this study. This may be due to the quality of the sequencing, 
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as many sequences were only partial amplifications, which may not have enough 
discriminatory power, or due to mutations in the genes, and needed further investigation.    
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5. FINAL CONSIDERATIONS 
The marine turtles, once abundant in tropical and temperate waters up to the 19th century, 
are now globally facing various threats. West Africa is home to some of the biggest Atlantic 
green sea turtle populations, therefore an important site for conservation. This study is not 
only the first scientific report of FP in Guinea-Bissau and Mauritania, but also the first time 
that the ChHV5 has been detected in these sites.  
Green sea turtles are under numerous environmental pressures, such as loss of habitat, 
degradation of the water quality, by-catch, illegal harvesting, among others. The recent 
epidemic outbreaks of FP are of pressing concern as they may pose an additional threat to 
the future survival of this vulnerable specie. Little is known about the pathology of this 
disease, but its presence in such an important population could bring negative 
consequences. The life-cycle of free-ranging sea turtles still has some lacunas, however it is 
know that they travel thousands of kilometres, establishing connections between distant 
areas. This connectivity between different geographical areas has been proven by the 
similarity of the viral variants. The spread of ChHV5 across the Atlantic may be due to the 
movement of the individuals, carrying the disease to previous naïve populations, expanding a 
local issue to a global issue (Patrício et al., 2016). This possibility should be investigated and 
may encourage the collaboration of the various marine turtle projects across the Atlantic.   
The ongoing climate change is also a global issue that is driving the adaption of marine turtle 
populations as well as bringing new threats. Emerging infectious diseases in marine 
ecosystems have increased in recent decades, reactivating previously latent diseases and 
introducing new, potentially fatal, diseases to the populations (Patrício et al., 2017). The 
future implications of the changes in climate on FP are uncertain, nonetheless, it should be 
closely studied as research has already shown its effect on other species (Patrício et al., 
2017).  
To better understand the dynamics of the green sea turtle population from West Africa (GB 
and MAU), further research is needed. This study has contributed by establishing a baseline 
of information on FP and ChHV5 prevalence. Recapture of the individuals is important to be 
able to study the evolution of FP afflicted turtles as well as to study the prevalence of the 
disease throughout the years. Patrício et al. (2016) showed that the prevalence of FP may 
fluctuate through the years, therefore long-term monitoring is beneficial.  
Future research should focus on more information regarding the health conditions of the 
turtles, which can be assessed through haematological data and water quality studies. 
Further molecular research should also be considered as it brings new insights to this old yet 
new disease. Success in the conservation of this marine species depends on measures that 
minimize the anthropogenic effects on their migratory path, foraging and nesting areas. Even 
though GB and MAU have successfully implemented these measures, sea turtles are global 
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animals, meaning these measures have to be considered worldwide.  
FP is a threat on an individual scale, nevertheless, understanding its impact on the 
population is fundamental for creating long-lasting conservation plans for the marine turtle 
population worldwide.  
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7. APPENDIX 
7.1. Supplementary material 1- Captured individuals’ morphometric information, sample quantification, Ct values and DNA 
viral copies.  
Turtle_ID Year Site Stage 
CCL 
(cm) 
FP 
lesions 
Tumour 
score 
DNA 
quantification 
Ct (normal skin) Ct (tumour) 
Viral copies 
(normal skin) 
Viral copies 
(tumour) 
1_MAU 2018 MAU Juvenile 61 yes 1 13,8 35.97 22,68 2,82E+02 2,82E+06 
2_MAU 2018 MAU Juvenile 57 no 0 34,7 42.21    
3_MAU 2018 MAU Juvenile 45,3 yes 1 25,7 35.14 24.18 5,01E+02 9,99E+05 
4_MAU 2018 MAU Juvenile 42 yes 1 19,3  20.26  1,51E+07 
5_MAU 2018 MAU Juvenile 57 no 0 17,9 40.01    
6_MAU 2018 MAU Juvenile 49,5 no 0 14,9 37.33  1,10E+02  
7_MAU 2018 MAU Sub-adult 66,5 no 0 12,7 36.81  1,58E+02  
8_MAU 2018 MAU Juvenile 64,5 no 0 34,9 32.81  2,52E+03  
9_MAU 2018 MAU Juvenile 55,3 no 0 19,4 35.22  4,74E+02  
10_MAU 2018 MAU Juvenile 48,6 no 0 12,3     
11_MAU 2018 MAU Juvenile 49,7 yes 1 13 34.10 38.35 1,03E+03  
12_MAU 2018 MAU Juvenile 57,3 no 0 14,8     
13_MAU 2018 MAU Juvenile 62,7 no 0 21,8 35.43  4,10E+02  
14_MAU 2018 MAU Juvenile 63,5 no 0 14,7 34.36  8,61E+02  
15_MAU 2018 MAU Juvenile 57,6 no 0 18,9 35.08  5,23E+02  
16_MAU 2018 MAU Juvenile 63,7 no 0 21,3 39.10    
17_MAU 2018 MAU Juvenile 62,3 no 0 20,2     
18_MAU 2018 MAU Juvenile 49,4 yes 1 13,4 37.30 21.63 1,12E+02 5,85E+06 
19_MAU 2018 MAU Juvenile 64,7 no 0 17,9 34.89  5,96E+02  
20_MAU 2018 MAU Juvenile 57,3 yes 1 16,6 33.88 32.77 1,20E+03 2,59E+03 
21_MAU 2018 MAU Juvenile 56,2 no 0 15,8 36.64  1,77E+02  
22_MAU 2018 MAU Juvenile 44,8 yes 1 24  20.61  1,19E+07 
23_MAU 2018 MAU Juvenile 59,7 yes 1 19,5 32.41 22.61 3,33E+03 2,96E+06 
24_MAU 2018 MAU Juvenile 57,1 no 0 12,8 33.21  1,91E+03  
25_MAU 2018 MAU Sub-adult 69,4 no 0 15,9 35.80  3,17E+02  
26_MAU 2018 MAU Sub-adult 68,9 no 0 18,4 37.78  80,44122  
27_MAU 2018 MAU Sub-adult 68,2 no 0 14,1     
28_MAU 2018 MAU Juvenile 63,5 no 0 7,1 39.51    
29_MAU 2018 MAU Juvenile 64,6 no 0 29,3 34.79  6,39E+02  
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Supplementary material 1- continuation  
Turtle_ID Year Site Stage 
CCL 
(cm) 
FP 
lesions 
Tumour 
score 
DNA 
quantification 
Ct (normal skin) Ct (tumour) 
Viral copies 
(normal skin) 
Viral copies 
(tumour) 
30_MAU 2018 MAU Juvenile 52,5 no 0 21.6 34.30  8,98E+02  
31_MAU 2018 MAU Juvenile 49,6 yes 1 12.5 32.66 31.88 2,80E+03 4,80E+03 
32_MAU 2018 MAU Juvenile 57,2 yes 1 22 33.71 30.63 1,35E+03 1,14E+04 
33_MAU 2018 MAU Juvenile 63,6 no 0 19.3 37.87  7,56E+01  
34_MAU 2018 MAU Juvenile 42,8 yes 1 30.3  22.26  3,78E+06 
35_MAU 2018 MAU Juvenile 64,1 no 0 13.4 36.87  1,51E+02  
36_MAU 2018 MAU Juvenile 46,4 yes 1 20.6  23.32  1,81E+06 
37_MAU 2018 MAU Sub-adult 65 no 0 19.2 33.34  1,75E+03  
38_MAU 2018 MAU Juvenile 58,3 yes 1 21.7  22.06  4,34E+06 
39_MAU 2018 MAU Juvenile 57,3 yes 1   21.10  8,44E+06 
40_MAU 2018 MAU Juvenile 58,2 yes 1  33.79 35.38 1,28E+03 4,25E+02 
42_MAU 2019 MAU Sub-adult 75,0 no 0      
43_MAU 2019 MAU Juvenile 57,0 no 0      
44_MAU 2019 MAU Juvenile 64,0 no 0      
45_MAU 2019 MAU Juvenile 63,3 no 0      
46_MAU 2019 MAU Sub-adult 65,4 no 0      
47_MAU 2019 MAU Juvenile 61,0 no 0      
48_MAU 2019 MAU Juvenile 56,0 yes 1      
49_MAU 2019 MAU Adult 96,0 no 0      
50_MAU 2019 MAU Sub-adult 66,0 no 0      
51_MAU 2019 MAU Juvenile 39,7 yes 2      
52_MAU 2019 MAU Juvenile 49,1 no 0      
53_MAU 2019 MAU Sub-adult 68,7 no 0      
54_MAU 2019 MAU Juvenile 55,2 no 0      
55_MAU 2019 MAU Juvenile 49,4 no 0      
56_MAU 2019 MAU Juvenile 53,9 yes 1      
57_MAU 2019 MAU Juvenile 49,5 no 0      
58_MAU 2019 MAU Juvenile 60,7 no 0      
59_MAU 2019 MAU Juvenile 50,0 no 0      
60_MAU 2019 MAU Sub-adult 73,3 no 0      
61_MAU 2019 MAU Juvenile 58,0 no 0      
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Supplementary material 1- continuation  
Turtle_ID Year Site Stage 
CCL 
(cm) 
FP 
lesions 
Tumour 
score 
DNA 
quantification 
Ct (normal skin) Ct (tumour) 
Viral copies 
(normal skin) 
Viral copies 
(tumour) 
62_MAU 2019 MAU Sub-adult 70,4 no 0      
63_MAU 2019 MAU Sub-adult 70,0 no 0      
64_MAU 2019 MAU Juvenile 51,8 no 0      
65_MAU 2019 MAU Juvenile 62,4 no 0      
66_MAU 2019 MAU Sub-adult 65,8 no 0      
67_MAU 2019 MAU Juvenile 60,0 no 0      
68_MAU 2019 MAU Sub-adult 73,4 no 0      
69_MAU 2019 MAU Juvenile 60,0 yes 3      
70_MAU 2019 MAU Juvenile 48,5 no 0      
71_MAU 2019 MAU Sub-adult 81,0 no 0      
72_MAU 2019 MAU Sub-adult 67,0 no 0      
73_MAU 2019 MAU Juvenile 61,6 yes 1      
1_GB 2018 GB Juvenile 44,5 no 0 8     
2_GB 2018 GB Juvenile 60,5 yes 1 14     
3_GB 2018 GB Juvenile 49,5 yes 3 14  32,055  4,25E+03 
4_GB 2018 GB Sub-adult 67 no 0 17.2 31.92  4,67E+03  
5_GB 2018 GB Juvenile 62,5 no 0 16.9     
6_GB 2018 GB Sub-adult 70 no 0 11.4     
7_GB 2018 GB Juvenile 62 no 0 12.4     
8_GB 2018 GB Juvenile 46 no 0 12.1 40.76    
9_GB 2018 GB Juvenile 61,2 no 0 20.4 38.15    
10_GB 2018 GB Juvenile 62,2 yes 1 13.1     
11_GB 2018 GB Adult 87,5 yes 3 9.4  21,695  5,59E+06 
12_GB 2018 GB Juvenile 45 no 0 6.9 38.08    
13_GB 2018 GB Juvenile 43 no 0 15.1     
14_GB 2018 GB Juvenile 47 no 0 18.5     
15_GB 2018 GB Juvenile 44,5 no 0 16 45.14    
16_GB 2018 GB Juvenile 60 yes 1 25.3     
17_GB 2018 GB Juvenile 56,5 no 0 29.5     
18_GB 2018 GB Juvenile 50 yes 1 11.8  26,63  1,83E+05 
19_GB 2018 GB Adult 92,5 yes 1 7.9 37.99  6,95E+01  
Supplementary material 1- continuation  
Turtle_ID Year Site Stage 
CCL 
(cm) 
FP 
lesions 
Tumour 
score 
DNA 
quantification 
Ct (normal skin) Ct (tumour) 
Viral copies 
(normal skin) 
Viral copies 
(tumour) 
20_GB 2018 GB Adult 97 no 0 22.4 36.85  1,53E+02  
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21_GB 2018 GB Juvenile 60 no 0 10.5 36.33  2,20E+02  
22_GB 2018 GB Juvenile 45,5 no 0 17     
23_GB 2018 GB Juvenile 37,5 no 0 12.4     
24_GB 2018 GB Juvenile 50 yes 1 24.2  28,58  4,12E+04 
25_GB 2018 GB Sub-adult 67 no 0 18     
26_GB 2018 GB Sub-adult 69 no 0 15.8     
27_GB 2019 GB Juvenile 57 no 0      
28_GB 2019 GB Adult 92 no 0      
29_GB 2019 GB Juvenile 38 no 0      
30_GB 2019 GB Juvenile 38 no 0  37,87  7,56E+01  
31_GB 2019 GB Juvenile 44 no 0      
32_GB 2019 GB Juvenile 49 yes 1  42,21    
33_GB 2019 GB Juvenile 63 no 0      
34_GB 2019 GB Sub-adult 65 yes 3   31,73  5,33E+03 
35_GB 2019 GB Juvenile 58 yes 1   44,98   
36_GB 2019 GB Juvenile 55,5 yes 1  44,23007    
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7.2. Supplementary material 2- GenBank accession numbers and sample information for phylogenetic analysis  
Sample 
ID 
Sampling Site Host species Sample year 
GenBank accession number 
Reference 
UL34 HP20 
U11 Guinea-Bissau Chelonia mydas 2018 - - 
Present study 
U18 Guinea-Bissau Chelonia mydas 2018 - - 
M1 Mauritania Chelonia mydas 2018 - - 
M4 Mauritania Chelonia mydas 2018 - - 
M18 Mauritania Chelonia mydas 2018 - - 
PR2 Puerto Rico Chelonia mydas 2009 JN580289 JN580293 
(Patrício et al., 2012) PR4 Puerto Rico Chelonia mydas 2010 JN580291 JN580295 
PR5 Puerto Rico Chelonia mydas 2010 JN580292 JN580296 
GG1 São Tomé e Principe Chelonia mydas 2009 JN625251 - 
(Duarte et al., 2012) 
GG2 São Tomé e Principe Chelonia mydas 2009 JN625252 - 
GG3 São Tomé e Principe Chelonia mydas 2009 JN625253 - 
GG4 São Tomé e Principe Chelonia mydas 2009 JN625254 - 
GG5 São Tomé e Principe Chelonia mydas 2009 JN625255 - 
GG6 São Tomé e Principe Chelonia mydas 2009 JN625256 - 
FL1 Florida Chelonia mydas 1990 AY646891 AY646912 
(Ene et al., 2005) 
FL2 Florida Caretta Caretta 1993 AY646888 AY646909 
FL3 Florida Caretta Caretta 1993 AY646890 AY646911 
FL4 Florida Chelonia mydas 1994 AY646892 AY646913 
FL5 Florida Caretta Caretta 1995 AY646889 AY646910 
FL6 Florida Lepidochelys kempii 2002 AY646894 AY646915 
FL7 Florida Chelonia mydas 1997 AF035004 - 
(Greenblatt et al., 2005; Quackenbush 
et al., 1998) 
HW1 Hawaii Chelonia mydas 2001 AY390416 - (Greenblatt et al., 2005) 
HW2 Hawaii Chelonia mydas 1995-1997 AY390417 - 
(Greenblatt et al., 2005; Quackenbush 
et al., 1998) 
AUS2 Australia Caretta Caretta 1999-2000 AY390412 - 
(Greenblatt et al., 2005; Quackenbush 
et al., 2001) 
BRB Barbados Chelonia mydas 1999-2000 AY390413 - 
(Greenblatt et al., 2005; Quackenbush 
et al., 2001) 
SD San Diego Chelonia mydas 1999-2000 AY390419 - (Greenblatt et al., 2005) 
CR Costa Rica Lepidochelys olivacea 1997 AY390414 - 
(Greenblatt et al., 2005; Quackenbush 
et al., 1998) 
 
